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ABSTRACT  
 
Background 
The incidence of type 2 diabetes has increased dramatically, particularly among 
Latinos. While several studies suggest the beneficial effect of lowering glycemic index 
and glycemic load in patients with type 2 diabetes, no data exists regarding this issue in 
the Latino population. The purpose of this study was to determine the effect of lowering 
glycemic index and glycemic load on diabetes control, lipid profiles and anthropometrics 
among Latinos with type 2 diabetes. 
Methods 
Subjects participated in a 12 month randomized clinical trial. The intervention targeted 
diabetes knowledge, attitudes and behavioral capabilities related to diabetes self 
management with content including nutrition and physical activity. The nutrition protocol 
emphasized reduction in glycemic index, fat, salt and portion size and increase in fiber. 
The control group was given usual care. Measurements included Hba1c, fasting 
glucose, total cholesterol (TC), low density lipoproteins (LDL) and high density 
lipoproteins (HDL), HDL:LDL ratio, TC:HDL ratio, waist circumference and BMI and 
were collected at baseline, 4 and 12-months. 
Results 
Two hundred fifty two Latino adults with type 2 diabetes participated in the study. 
Baseline mean  HbA1C was 8.98% (SD=1.87), BMI was 34.76 kg/cm (SD=6.94), age 
was 56 (SD=11.18) years and 76% were female. Reduction in glycemic index was 
positively associated with a reduction in logHbA1c (p=0.006), HDL:LDL ratio (p=0.037) 
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and waist circumference (p=0.003) overtime, but not with fasting glucose, TC, LDL and 
HDL, TC:HDL ratio, body weight or BMI. No significant associations were found 
between glycemic load and any measures. 
Conclusion 
Results suggest that lowering glycemic index may have a positive effect on some 
markers of diabetes control, lipid profiles and anthropometrics among Latinos with type 
2 diabetes, but not others. While statistically significant reductions in GI and GL were 
noted, the actual reduction was small. Thus, greater reduction in GI and GL may be 
needed for clinical significance and greater effect on metabolic outcomes. Future 
research should target populations with higher baseline GI and GL.  
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CHAPTER I  
Proposal 
Specific aims 
The incidence of type 2 diabetes (T2D) has increased at a dramatic rate over the 
past several decades. This chronic illness is reaching epidemic proportions in the 
United States, currently affecting approximately 12.9% of the adult US population [1]. 
Latinos suffer higher rates of T2D [1], and higher rates of uncontrolled T2D [2, 3] which 
fosters long-term microvascular complications and an eventual increase in 
macrovascular complications including cardiovascular disease and stroke [4].  
Blood glucose response to the ingestion of carbohydrate-containing foods has 
been shown to vary dramatically depending on various factors. The glycemic index (GI) 
is the value given to carbohydrate-containing foods indicating the blood glucose 
response they elicit [5]. Lower GI foods are foods, which provoke a slower, more 
sustained blood sugar response; GL is a combination of the GI and the quantity of 
carbohydrate in a food. Results of recent clinical trials suggests that consumption of a 
low GI (LGI) diet may result in improved diabetes control compared to a high GI(HGI) 
diet in individuals with T2D [6-10]. Additionally, results of several large epidemiological 
studies suggest a protective effect of lowering GL on diabetes risk [11, 12]. However, no 
clinical trial has investigated the effects of a low GL (LGL) diet compared to a high GL 
(HGL) diet in adults with T2D. Furthermore, no study has investigated the effects of 
lowering GI in Latinos. Given that Latinos have a high prevalence of T2D and that 
consumption of LGI or LGL foods may result in improved glycemic control, an 
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examination of the quality of carbohydrate intake among Latinos with T2D, and the 
association between GI and GL and clinical endpoints, may have great public health 
implications. 
The goals of this study are to investigate the association of GI and GL on 
measures of diabetes control, anthropometrics and lipid profiles among low-income 
Latino individuals with T2D. These research questions will be addressed through 
secondary analysis of a randomized controlled trial (RCT), Latinos en Control, which 
tested the efficacy of a diabetes self-management intervention that targeted GI and GL 
among two hundred fifty-two Latino patients of Caribbean origin with T2D. Individuals 
were recruited from five community health centers in urban areas of central and western 
Massachusetts. The group-based intervention, targeted diabetes knowledge, attitudes 
and behavioral capabilities and its content was tailored to the cultural and literacy needs 
of the population. Personalized coaching was offered within the context of the 
intervention format (10-minute counseling segments prior to the group start). 
Assessments were completed at baseline, 4 and 12 months and included three 24-hour 
dietary recalls, clinical assessments, and demographic and psychosocial interviews.  
The study’s specific aims and related hypotheses are described below.  
1. Determine the effect of GI or GL on glucose control determined by glycosylated 
hemoglobin (HbA1c) and fasting blood glucose levels. 
Hypothesis:  
a. Compared to usual care participants, intervention participants will achieve a 
greater reduction in dietary GI and GL and improved diabetes control. 
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2.  Determine the effect of GI or GL on lipid profile determined by total cholesterol (TC), 
high density lipoproteins (HDL), low density lipoproteins (LDL), and triglycerides. 
Hypothesis:  
a. Compared to usual care participants, intervention participants will achieve a 
greater reduction in dietary GI or GL and improved lipid profiles. 
 
3. Determine the effect of GI or GL on anthropometrics determined by BMI and waist 
circumference. 
Hypothesis:  
a. Compared to usual care participants, intervention participants will achieve a 
greater reduction in dietary GI or GL and improved anthropometric outcomes.  
 
Background and significance 
Diabetes prevalence 
The incidence of diabetes has increased at a dramatic rate over the past several 
decades. This chronic illness is reaching epidemic proportions in the United States, 
currently affecting approximately 12.9% of the adult US population [1] and the burden is 
not restricted to the United States alone. By the year 2025 it is predicted that the 
number of individuals living with diabetes worldwide will reach 300 million [13].  
Diabetes disease process 
T2D is a progressive metabolic disorder. It is often characterized by years of 
asymptomatic insulin resistance and subsequent hyperglycemia. The result of this 
continuous glucose dysfunction is destruction of pancreatic beta cells. If these 
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conditions persist, the emergence of complete T2D will occur. The etiology of T2D is not 
completely understood. Researchers have proposed two potential mechanisms for the 
progression to beta-cell death, as seen in T2D. One potential mechanism is the over-
secretion of insulin as a result of repetitive hyperglycemic events. The second is that 
repetitive hyperglycemia itself has a toxic impact on beta cells [14]. 
Diabetes related complications 
Chronically elevated blood glucose and subsequent increased insulin demands foster 
long-term microvascular complications and an eventual increase in macrovascular 
complications, including cardiovascular disease and stroke. Recent research indicates 
that elevated blood glucose, even below the threshold for diabetes, is a leading cause 
of cardiovascular mortality. According to a recent study, 21% of global ischemic heart 
disease and 13% of stroke mortality is attributable to higher-than-optimum blood 
glucose [4].  
Latinos and diabetes control 
Latinos suffer higher rates of T2D. Results of a recent study suggest that the combined 
crude prevalence of diagnosed and undiagnosed diabetes is 80% higher in Mexican 
Americans compared to non-Latino whites after controlling for age and gender [1]. 
Furthermore, Latinos have high rates of uncontrolled T2D [2, 3] which fosters long-term 
microvascular complications and an eventual increase in macrovascular complications 
including cardiovascular disease and stroke [4]. The projected increase in diabetic 
retinopathy for Latino adults over age 65 with T2D by the year 2050 is 0.5 million [15]. 
Additionally, projections suggest a 12 fold increase in diabetes related glaucoma in 
Latino adults over age 65 with T2D by the year 2050 [15].  
5 
 
Medical nutrition therapy for the management of type 2 diabetes 
Previous research suggests that improvements in dietary behaviors can have beneficial 
effects on diabetes management. As a result of this research, professional 
organizations, which focus on diabetes care offer practice recommendations for 
diabetes management through dietary behavior change. The American Diabetes 
Association (ADA) evidence-based treatment guidelines include specific dietary 
recommendations in conjunction with pharmacological interventions and other self-
management strategies  (i.e., blood glucose monitoring and physical activity)[16]. 
Several ADA diet-related recommendations include carbohydrate quality, dietary fat 
intake and weight management and these are described below.  
Carbohydrate Quality  
The ADA recommends dietary intake of carbohydrates from various sources including: 
fruits, vegetables, whole grains, legumes, and low-fat milk. The ADA’s current position 
[16] suggests the use of GI and GL as a strategy for improving diabetes management. 
Both may offer some benefit over that seen when total carbohydrate is considered 
alone. Additionally they encourage consumption of a variety of fiber-containing foods, 
but suggest a lack of evidence to recommend fiber intakes higher than is recommended 
for the general population. 
Dietary Fat 
The principle recommendation regarding dietary fat in patient’s withT2D is to limit 
saturated fatty acids, trans fatty acids, and cholesterol intakes to reduce risk for CVD. 
Weight Management 
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Recommendations for dietary management for individuals with T2D emphasize  the 
implementation of lifestyle changes that will improve glycemia, dyslipidemia, and blood 
pressure. Modest weight loss (5% of body weight) in overweight individuals with T2D 
has been shown to improve insulin resistance, measures of glycemia, lipid levels and 
blood pressure [16]. 
Glycemic Index and Glycemic Load 
Blood glucose response to the ingestion of carbohydrate-containing foods has been 
shown to vary dramatically depending on factors including the molecular structure of the 
carbohydrate, fiber content, and degree of processing [17]. Refined, highly processed 
carbohydrates are broken down and absorbed quickly, resulting in a rapid increase in 
blood glucose, whereas less refined carbohydrates are absorbed more slowly, resulting 
in a slower, more sustained rise in blood glucose. GI is the value given to carbohydrate-
containing foods indicating the blood glucose response they elicit. The GI [5] of a food is 
defined as the incremental area under the glucose response curve relative to that 
produced by a standard control food (either glucose or white bread). The GI was 
developed as a tool to standardize measurement of glycemic responses to ingestion of 
carbohydrate containing foods. Simplistically, GI is a measure of how much and how 
fast a carbohydrate containing food raises blood glucose levels. High GI (HGI) foods 
induce a rapid spike in blood glucose, while low GI (LGI) foods elicit slower, lesser, and 
more sustained increases in blood glucose levels. Using glucose as referent, HGI foods 
are foods with GI values greater than or equal to 70, medium GI is 55-69 and LGI is less 
than 55. The GI of the average diet in the US has increased over time as more highly 
processed foods are being consumed. [18]. Currently, most commonly consumed 
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carbohydrates in the United States are high-glycemic carbohydrates. The current mean 
GI intake of the Latino population has not been reported.  
To account for carbohydrate content variation with in foods, GL was introduced in 
1997 by Willett and colleagues and can be calculated as the quantity (in grams) of a 
food’s carbohydrate content, multiplied by its GI. [19] HGL foods are foods with GL values 
greater than or equal to 20, medium GL is 11-19 and LGL is less than or equal to 10. 
In healthy individuals, blood glucose level is tightly maintained by homeostatic 
regulatory systems. However, the physiological effects of ingestion of high glycemic 
foods challenge these mechanisms. The rapid increase in blood glucose following 
consumption of a high glycemic meal stimulates insulin release and inhibits glucagon 
release to a much greater extent than after consumption of a low glycemic meal. This 
results in exaggerated glucose uptake by skeletal muscle, storage of fat, and inhibition 
of fat breakdown. The major metabolic fuels – glucose oxidation and free fatty acids – 
are suppressed. Nutrient absorption from the gastrointestinal tract then declines while 
the biological effects of insulin release and glucagon suppression persist, resulting in a 
rapid fall in blood glucose levels, often into the hypoglycemic range. The low levels of 
metabolic fuels trigger a counter-regulatory hormone response, increasing free fatty 
acids, and creating a fasting physiological state. Research to date suggests that 
stimulation of these exaggerated physiological responses repeatedly over time may 
promote excessive food intake, beta cell dysfunction, dyslipidemia, and endothelial 
dysfunction; increasing risk for obesity, diabetes, and heart disease [17].  
Previous Research 
Primary Prevention 
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Several large cohort studies have investigated the relationship between GI, GL and 
risk of diabetes. While the majority of these studies have indicated a protective 
relationship between lowering GI and reduced risk of diabetes, several have not. 
Results from the Nurses’ Health Study [11], the Nurses’ Health Study II [20], the Health 
Professional Follow-up Study [19], the US Black Women Study [21], and the Shanghai 
Women’s Health Study [12] found that higher GI was positively associated with risk of 
diabetes after adjustment for covariates. However, the Iowa Women’s Health study [22] 
showed no association between higher GI and risk of diabetes. Another study 
conducted in White and African American adults found no association between GI and 
risk of diabetes [23]. The results of studies highlighting the relationship between GL and 
risk of diabetes have also been inconsistent. Results from the Nurses’ Health Study [11] 
and the Shanghai Women’s Health Study [12] suggest that higher GL is positively 
associated with risk of diabetes. In contrast, results from the Health Professional Follow-
up Study [19], the US Black Women Study [21] and the Nurses’ Health Study II [20] 
showed no significant relationship between higher GL and risk of diabetes. Additionally, 
a recent meta analysis of 45 observational studies in adults, suggested that a lower GI 
diet is associated with lower fasting blood glucose and glycosylated hemoglobin [24].  
The participants in the Latinos en Control study represent a demographic not 
addressed by previous studies in this area, one that is known to have elevated rates of 
T2D and T2D related complications. The Nurses’ Health Study investigated the 
relationship between G and GL in female nurses between 30-55 years at initiation [11] 
and the relationship GI and GL in young and middle age female nurses aged 24-44 
years at initiation [20]. The Health Professional Follow-up Study [19] included only men, 
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the US Black Women Study [21] included only Black women and the Shanghai 
Women’s Health Study [12] included only Chinese women. 
Secondary Prevention  
While no clinical trial has assessed the effects of a LGL diet compared to a HGL 
diet in individuals with T2D, one study [25] did examine the effects of a LGL diet 
compared to a HGL diet on risk factors for T2D in healthy overweight adults. The results 
showed no significant differences in diabetes risk factors between the HGL and LGL 
groups after the 6-month weight loss intervention. One possible explanation for the lack 
of difference between the two groups is that the participants did not have diabetes, thus 
not enough metabolic dysfunction to impact a change in outcomes.  
Several clinical trials [6, 8-10, 26-29] have investigated the effect of lowering 
dietary GI on metabolic and anthropometric outcomes in subjects with T2D, results have 
been inconsistent. Nevertheless, findings from several of these studies suggest that 
incorporation of GI principles into diabetes care has substantial promise for improving 
management of T2D without evidence of adverse effects. Most of the studies comparing 
LGI diets to HGI diets on individuals with T2D [6, 9, 28, 29] have been conducted with 
small samples and for short duration, most lasting less than 6 weeks for each dietary 
condition [6, 9, 26-29]. All but one were conducted among patients with variable or 
uncontrolled type 2 diabetes [6-9, 26-29]. While several studies have shown greater 
improvements in diabetes control with a LGI diet compared to a HGI diet [6-10] several 
have not [26, 27, 29]. Two studies investigated the impact of a LGI diet compared to an 
HGI diet on anthropometric outcomes in individuals with T2D. Results of one study 
suggest that body weight did not differ significantly between diets [10]; another found no 
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difference in lean or fat mass between the two diets [9]. Several studies have shown 
improvements in lipid profiles, including HDL, LDL and TC [9, 26, 29] while no study 
showed an improvement in triglycerides. One study showed no improvement in any lipid 
marker[6].  
The largest and longest clinical trial assessed the effect of a LGI dietary 
intervention compared to either a HGI or a low- carbohydrate dietary intervention in 
well-controlled individuals with T2D. One hundred and sixty two subjects participated in 
a 1 year multicenter, randomized controlled trial in which the impact of the 3 diets (a low 
GI, a high GI and a low carbohydrate diet) on HbA1c, blood glucose, lipids, and CRP 
were assessed. The results suggested that body weight and HbA1c did not differ 
significantly between diets. Fasting glucose was higher, but 2-h postprandial glucose 
was lower after 12 mo of the low-GI diet. One potential reason for the lack of difference 
in HbA1C between the HGI and LGI dietary prescriptions is that the subjects in this 
study had optimal HbA1C levels at baseline, thus reduction in HbA1C may have been 
difficult to attain [10]. 
Summary of significance 
While many epidemiological studies suggest the beneficial effect of reducing dietary GI 
or GL in patients with T2D, little data exists regarding this issue in the Latino population. 
While several clinical trials [6, 8-10, 26-29] have investigated the association between 
lowering dietary GI and diabetes related health outcomes of patient’s with T2D, the 
results have been inconsistent. Furthermore, only one clinical trial has assessed 
metabolic or anthropometric outcomes in Latinos with T2D and no clinical trial has 
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assessed the effects of lowering GL on metabolic or anthropometric outcomes in 
individuals with T2D.  
This proposed investigation addresses several limitations of the previous 
research in this area. First, the target population is comprised of Latinos with poorly 
controlled T2D, a population in which this research question has not been previously 
investigated. Therefore, the results of this study will address a significant health concern 
within a population at great risk. Second, the duration of this intervention, 1 year, is 
longer than all but one previous clinical trial [10]. While results of a few shorter trials do 
suggest a positive impact of lowering GI on metabolic outcomes in adults with T2D [6-
10], the longer term effects need to be investigated. Third, while Wolever et al. [10] 
conducted a 1 year trial, the sample included Canadian adults with well controlled T2D; 
it is possible that reducing GI or GL in adults with poorly controlled T2D over an 
extended period of time may result in greater reductions in metabolic and 
anthropometric outcomes compared to individuals with well controlled T2D at baseline.  
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CHAPTER II 
The Association between Glycemic Index, Glycemic Load and Glycemic Control 
among Low-income Latinos with Type 2 Diabetes 
 
 
 
ABSTRACT 
Background 
Type 2 diabetes has increased dramatically over the past decades. Latinos suffer higher 
rates of type 2 diabetes compared to non-Latino whites. While many studies suggest 
the beneficial effect of reducing glycemic index (GI) and glycemic load (GL) in patients 
with type 2 diabetes, little clinical data exists regarding this issue in the Latino 
population.  
Purpose 
To determine the effect of a 12 month diabetes self-management intervention on GI and 
GL intake and the effect of changes in GI and GL on glucose control determined by 
glycosylated hemoglobin (HbA1c) and fasting blood glucose levels among low-income 
Latino adults with type 2 diabetes. 
Methods 
The 12 month intervention targeted diabetes knowledge, attitudes and behavioral 
capabilities and its content was culturally and literacy tailored. Measurements were 
collected at baseline, 4 and 12-month follow-up and included three 24-hour dietary 
recalls, clinical assessments, and demographic and psychosocial interviews. 
Multivariate random effects analyses were used to test the association between GI and 
GL with HbA1c and fasting blood glucose overtime.  
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Results 
252 Latinos with type 2 diabetes participated in the study. The baseline mean (SD) 
HbA1c was 8.98 (1.87), age was 56 (11.18) years, and 76.6 % were female. A 
significant reduction in mean GI and GL (p<0.001, p<0.001, respectively) was noted at 4 
months in the treatment group compared to the control group; at 12 months this 
reduction only remained significant for mean GL (p<0.001). A reduction in GI was 
associated with a reduction in logHbA1c (p=0.006), but not with fasting blood glucose 
(p=0.138). No significant associations between GL and HbA1c or fasting blood glucose 
were observed (p=0.124, p= 0.604, respectively). 
Conclusion 
Results suggest that the Latinos en Control intervention was effective in lowering GI and 
GL, though changes were most pronounced in the short term and were maintained only 
for GL. This study adds to the evidence suggesting that lowering dietary GI may 
enhance type 2 diabetes control in an understudied population of low income Latinos. 
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INTRODUCTION 
 
The incidence of type 2 diabetes (T2D) has increased at a dramatic rate over the 
past several decades. This chronic illness is reaching epidemic proportions in the 
United States, currently affecting approximately 12.9% of the adult US population [1]. By 
the year 2025, it is predicted that the number of individuals living with diabetes will 
reach 300 million worldwide [13].  
Latinos suffer higher rates of T2D then non-Latino Whites. Results of a recent 
study suggest that the combined crude prevalence of diagnosed and undiagnosed 
diabetes is 80% higher in Mexican Americans compared to non-Latino whites after 
controlling for age and gender [1]. Furthermore, Latinos have high rates of uncontrolled 
T2D [2, 3] which fosters long-term microvascular complications and an eventual 
increase in macrovascular complications including cardiovascular disease and stroke 
[4].  Additionally, researchers have projected an additional 500,000 cases of diabetic 
retinopathy and a 12-fold increase in diabetes related glaucoma among Latino adults 
over the age of 65 by 2050 [15].  
Blood glucose response to the ingestion of carbohydrate-containing foods has 
been shown to vary dramatically depending on various factors. The glycemic index (GI) 
is the value given to carbohydrate-containing foods indicating the blood glucose 
response they elicit [5]. Lower GI foods are foods which provoke a slower, more 
sustained blood sugar response. Glycemic load (GL) is a combination of the GI and the 
quantity of carbohydrate in a food. Recent clinical trials suggest that consumption of a 
low GI diet may result in improved diabetes control compared to a high GI diet in 
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individuals with T2D [6-10]. Moreover, several large epidemiological studies suggest a 
protective effect of lowering GL on diabetes risk [11, 12]. However, no clinical trial has 
investigated the effects of a low GL diet compared to a high GL diet in adults with T2D.  
Furthermore, only one other study has investigated the effects of lowering GI in Latinos 
[28]. Given that Latinos have a high prevalence of T2D and that consumption of low GI 
or low GL foods may result in improved glycemic control, an examination of the quality 
of carbohydrate intake among Latinos with T2D, and the association between GI and 
GL and clinical endpoints is of great importance. The purpose of this study was to 
determine the effect of a diabetes self management intervention on GI and GL, and the 
effect of these changes on glucose control as assessed by glycosylated hemoglobin 
(HbA1c) and fasting blood glucose levels among low-income Latinos with T2D. 
 
METHODS 
Study Participants 
Patients with T2D were recruited from five community health centers (CHC) in 
urban areas of central and western Massachusetts.  At each CHC, a trained site 
research coordinator overseen by the research team was responsible for completing the 
recruitment processes. Subjects were included if they: were diagnosed with T2D;had an 
HbA1c level > 7.5; were currently  being treated with diet, oral hypoglycemics or insulin 
and, if they were currently on insulin, they must have had a history of prior therapy with 
diet alone or oral hypoglycemic agents; were Latino origin; were > 18 years old; had a 
telephone in home or easy access to one;  were able to understand and participate in 
the study protocol and functionally capable of meeting the physical activity goals; 
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understood and could provide informed consent; and were given physician approval to 
participate in the study. Subjects were excluded if they: had a history of diabetic 
ketoacidosis; current gestational diabetes; were unable or unwilling to provide informed 
consent; had any plans to move out of the area within the 12-month study period; 
required intermittent glucocorticoid therapy within the past 3 months; experienced an 
acute coronary event within the previous 6 months or had any medical condition that 
precluded adherence to study dietary recommendations or had any major psychiatric 
illness.   
Determination of subject eligibility and recruitment was conducted in several 
stages. First, health care providers at participating CHCs were notified of the study and 
their approval for the site research coordinator to access patient medical records for 
screening purposes was obtained. Second, a review of the medical records of 
potentially eligible patients’ was completed. For patients determined to be medically 
eligible to participate, approval and a signature on the recruitment letter was obtained 
from their primary care physician. Third, a letter describing the study was mailed to the 
patients who received primary care physician approval. Prior to participation in the study 
written informed consent was obtained from all participants. Once the baseline 
assessment was completed, participants were randomized to either the usual care 
condition or to Latinos En Control intervention condition. Randomization was completed 
at the level of the individual and stratified by CHC site, gender, baseline HbA1c levels 
and insurance status. Within each strata, participants were randomized in randomly 
allocated blocks of size 2, 4 and 6 using a reallocation program [30] version 7.0 (Stata 
Corporation, College Station, TX). Block randomization was used to ensure blinding of 
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the allocation sequence. The study protocol was approved by the University of 
Massachusetts Medical School’s and the Baystate Medical Center’s Institutional Review 
Boards. 
Intervention 
Participants in the intervention condition, Latinos en Control, participated in a one 
year, group based intervention, consisting of two phases: an intensive phase with 12 
weekly sessions followed by a maintenance phase with 8 monthly sessions. An outline 
of the self-management curriculum is presented in Table 1. The intervention targeted 
diabetes knowledge (e.g., effect of foods of different GI on diabetes control), attitudes 
(e.g., self-efficacy for dietary change) and behavioral capabilities (i.e., skills needed to 
make lifestyle changes) with its content tailored to the cultural and literacy needs of this 
population.  Personalized coaching was offered during 10-minute counseling segments 
prior to the start of each group.  
The dietary component of the intervention used the metaphor of a traffic light to 
simplify complex concepts. Foods frequently consumed by Latinos were classified 
based on their GI, fat, salt, and fiber content into categories of “green”, “yellow,” or “red” 
foods. A “food guide” which included pictures of these foods within the corresponding 
“traffic light colors” was developed and provided to all participants. Additionally, 
participants were given a graphic of a plate which displayed the ideal balance of colors 
at any given meal. Explained simplistically, the color green classified recommended 
foods which were lower in calories, saturated or trans-fat and sodium content and were 
of lower GI.  “Yellow” foods were medium in calories, saturated or trans-fat and sodium 
content and were of medium GI.  “Red” foods were higher in calories, saturated or 
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trans-fat and sodium content and were of higher GI. To impact GL, reduction of portion 
sizes was emphasized and all participants received a set of measuring cups. Subjects 
participated in multiple interactive sessions including: healthy cooking methods for 
ethnic foods, label reading, a supermarket tour, group meals where measuring cups 
were used for modeling appropriate portion sizes and guided discussions explored taste 
and appeal of the foods, the ease of preparation, and strategies to incorporate new 
cooking methods at home. Participants were provided with and instructed in the use of 
glucose meters and step counters.  
Usual care was defined as diabetes care as currently delivered at the CHC. 
Therefore, participants in the usual care group received medical therapy as determined 
to be appropriate by their healthcare providers. Healthcare providers received all 
laboratory reports for all participants regardless of their study condition. 
Measurement 
Measurements were collected at baseline, 4 and 12-month follow-up and 
included three 24-hour recalls, clinical assessments, and demographic and 
psychosocial interviews at each time point. Dietary intake and physical activity [31] were 
assessed via three unannounced telephone administered 24-hour recalls. Multiple 
recalls are used to assess day-to-day intra-individual variations in the behaviors of 
interest [32]. The Minnesota Nutrition Coordinating Center’s (UM-NCC) Nutrition Data 
System for Research software (NDS-R) was used to collect and analyze the 24-hour 
dietary recall data [33].  At each assessment visit, fasting blood samples were drawn for 
analysis of TC, LDL, HDL and triglycerides, fasting glucose, and HbA1c. Body Mass 
Index (BMI) was calculated as weight in kg divided by height in cm². Weight was 
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assessed with a Tanita BWB800S Digital Physicians Scale and Height was asses with a 
Seca Road Rod Portable Stadiometer.  Waist circumference was measured in 
centimeters to 0.1 cm.  Waist circumference was measured twice and the mean value 
was used in the analyses. Two blood pressure measurements were taken using a 
Dinamap XL automated BP monitor.  All medications and supplements were recorded. 
Demographic and additional data were collected via self-reported survey, including; 
age, gender, education level, and duration of diabetes. In order to account for the 
potential effect of medications on blood glucose, lipids, and weight, two pharmacists 
compiled the medication used by study participants based on whether they had a 
positive or adverse effect on these outcomes. In addition, glucose lowering agents were 
combined to construct a diabetes medication intensity score. This score was based on 
the type of oral hypoglycemics taken and/or dose and type of insulin taken. Possible 
scores ranged from 0- 6.5, with a higher score equating to greater number or dose of 
medication/insulin. Participants were compensated with 30 dollars at each assessment 
timepoint.  
Statistical Analysis 
 
All analyses were performed using STATA version 11 (StataCorp, College 
Station, TX). Results are expressed as means with 95% confidence intervals (CIs) for 
continuous variables and n(%) for categorical variables. Descriptive statistics were 
calculated for continuous covariates (age, BMI, physical activity, blood pressure, 
medication score), exposure variables (GI, GL), and outcomes (HbA1c, fasting blood 
glucose). The natural logarithm of HbA1c was used in the multivariate analyses 
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because the distribution was skewed. Although GI and GL were continuous variables, 
for univariate statistical inferences, data were stratified by baseline GI and GL quartile 
and compared differences of baseline demographic and clinical data using Chi-Square 
or ANOVA tests.   
          Four separate random effects regression models were developed with either the 
outcome being log (HbA1c) or fasting blood glucose and the primary predictor of 
interest being the exposure variable of GI or GL (ie, a model examining the effect of GI 
on HbA1c adjusted for other confounders, followed by a model examining GL on HbA1c 
and then repeated for fasting blood glucose). Each model was controlled for age, 
gender, mean arterial blood pressure, total energy intake, physical activity, diabetes 
medication intensity score, lipid increasing and decreasing drugs, and weight increasing 
and decreasing drugs and study arm. A backward elimination process was used for 
each model, until only significant variables remained. Additionally, linear regression was 
used to determine the association between change in glycemic index and glycemic load 
with change in logHbA1c and fasting blood glucose from baseline to 4 months follow-up.  
The primary multivariate analysis was a complete case analysis in which patient 
records with missing values were not in the regression models.  To investigate the 
potential effect of missing data, two imputed sensitivity analyses were completed. The 
first analysis was intention to treat analysis, which included all 252 randomized 
participants, with the baseline observation carried forward when missing values were 
present. The second method relied on multiple imputation by chained equations (MICE) 
analysis [34]. No differences were found between the analyses. Thus, results using 
complete data are presented herein. 
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RESULTS 
Baseline Characteristics 
The participant flow diagram is shown in Figure 1. A total of 252 Latino adults 
with T2D participated in the study, 128 randomized to the control condition and 124 to 
the intervention condition. Table 2 presents baseline demographic and clinical data 
stratified by baseline GI and GL quartiles determined by the average of the three 
baseline dietary recalls. The baseline mean (SD) HbA1c was 8.98% (±1.87%), age was 
56.0 (±11.2) years, and 76% were female. There was a significant difference in HbA1c 
by GI quartile. Subjects in the lowest quartile of GI had significantly lower mean HbA1c 
compared to those in the other three quartiles (8.23% vs. 9.35%, 9.04% and 9.20%, 
p=.005) but this pattern was not found with the GL quartiles. Significantly more females 
were in the lowest quartile for GL (90% vs.78%, 73%, 88%, p=.033), but there was no 
gender difference by GI quartile.  
At baseline, 44% of subjects were taking oral hypoglycemic medications only, 
40% were taking oral agents and insulin, 9% were taking insulin therapy only and 7% 
were taking no medications. The distribution of the medication intensity score did not 
differ across GI or GL quartiles. GI intake at baseline ranged from 46.58-76.02 (glucose 
reference) and GL intake at baseline ranged from 30.14-299.42.  
Intervention Effects 
Glycemic Index 
Figures 2 and 3 illustrate the change in GI and GL over time by treatment group 
compared to the control group. A significant reduction (baseline minus 4 month value) in 
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mean GI was seen in the treatment group at 4 months (treatment -2.57 (7.25) vs. 
control 0.87 (5.95), p<0.001).  However, while this trend remained, the difference 
between conditions was no longer statistically significant at 12 months (treatment -0.63 
(7.15) vs. control 0.42 (5.96) vs., p=0.27). Subjects in the highest quartile of GI at 
baseline showed greater reduction in GI compared to all other quartiles at 4 months 
(treatment 0.5 (6.80) vs. control -4.84 (5.4), p<0.001) and 12 months (treatment 1.48 
(6.2) vs. control -5.22 (4.9), p<0.001).  Subjects in the lowest GI quartile at baseline 
increased GI at 4 months (treatment -2.06 (6.55) vs. control 2.97 (6.55), p<0.001), and 
12 months (treatment -2.09(5.38) control 5.67(6.26), p<0.001) compared to other 
quartiles.  
Glycemic Load 
A significant reduction in mean GL was seen in the treatment group compared to 
the control group at 4 months (treatment -20.42 (46.87) vs. control 7.41 (44.12), p 
<0.001), and at 12 months (treatment-14.62 (46.82) vs. control 6.48(43.15), p <0.001).  
Like what was observed with GI, subjects in the highest GL quartile at baseline 
decreased GL at 4 months (treatment 4.29 (38.87) vs. control -37.53 (56.35), p<0.001) 
and 12 months (treatment 8.69 (38.22) vs. control -39.66 (48.48), p<0.001) and those in 
the lowest GL quartile at baseline increased GL at 4 months (treatment-2.07 (6.56) vs. 
control 2.98(6.27), p<0.001) and 12 months (treatment -2.09 (5.38)vs. control 
5.66(6.26), p<0.001).  
There was no statistically significant association between change in glycemic index or 
glycemic load with change in HbA1c or fasting blood glucose from baseline to 4 months 
follow up.  
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Overall Association of Glycemic Index and Glycemic Control 
Table 3 and Table 4 present the results of the multivariate random effects 
regression models. A decrease in GI was associated with a statistically significant 
decrease in the logHbA1c (0.003, 95%CI [0.001 to 0.006], p=0.009), but not with fasting 
blood glucose (0.736, 95%CI [-0.237 to 1.710], p=0.138).  
Overall Association of Glycemic Load and Glycemic Control 
No significant associations between GL and HbA1c or fasting blood glucose were 
found (0.000, 95%CI[-0.000 to 0.001],p=0.189, and 0.035, 95%CI[-0.097 to 0.166], p= 
0.604, respectively). 
 
DISCUSSION 
While several studies have shown greater improvements in glycemic control with 
a low GI diet compared to a high GI diet [6-10] several have not [26, 27, 29]. Most of the 
studies comparing low GI diets to high GI diets on individuals with T2D [6, 9, 28, 29] 
have been conducted with small samples and for short duration, most lasting less than 
6 weeks for each dietary condition [6, 9, 26-29]. The largest and longest clinical trial 
assessed the effect of a low GI dietary intervention compared to either a high GI or a 
low-carbohydrate dietary intervention in individuals with well-controlled T2D [35]. One 
hundred sixty two subjects were followed for 1year as part of this randomized controlled 
trial (in which the impact of the three diets on glycemic control assessed by HbA1c, 
blood glucose, lipids, and CRP were assessed). The results suggested that body weight 
and HbA1c did not differ significantly between the low GI, high GI and low-carbohydrate 
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diets. Fasting glucose was higher, but 2 hour postprandial glucose was lower after 1 
year of the low-GI diet compared to the other two diets. One potential reason for the 
lack of difference in HbA1c between the  high GI and  low GI dietary prescriptions is that 
the subjects in this study had optimal HbA1c levels at baseline, thus reduction in HbA1c 
may have been difficult to attain [10]. Only one study has previously investigated the 
effect of lowering GI in Latino subjects with T2D. Jimenez-Cruz et al. [28] conducted a 
6-week crossover study feeding study in which 14 overweight and obese Mexicans with 
T2D were given a low-GI diet, containing Mexican-style foods and then a high GI diet. 
The results suggest improvements in HbA1c during the low GI diet, compared to the 
high GI diet.  
Glycemic Index 
High GI foods are foods with GI values greater than or equal to 70, medium GI is 55-69 
and low GI is less than 55. Currently, most commonly consumed carbohydrates in the 
United States are refined, higher-glycemic carbohydrates [18].The typical Western style 
diet contains many starchy foods such as potatoes, white breads and rice most of which  
have a GI greater than 70 (glucose reference). However, the mean GI intake for all 
subjects in this study at baseline was 61 (range 46.58-76.02), which is classified as 
medium GI. Thus, the mean GI in this population was lower than expected.  
Subjects with the highest GI at baseline showed greater reduction in GI at each 
time point. Alternatively, subjects with the lowest GI increased GI at each time point. 
These data suggest that interventions which target reducing GI may be more effective in 
individuals with higher GI intake.  Perhaps targeting Latinos for reduction in GI alone is 
not as efficacious as targeting the reduction of portion size, which would result in a 
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reduction in GL.  Additionally, while changes in GI were statistically significant, the 
absolute reduction in GI was very small. Greater reductions in GI might be needed to 
see a more significant reduction in clinical biomarkers. However, as this population had 
a lower mean baseline GI, it is possible that greater reductions in this population are not 
feasible.  
HbA1c 
A reduction in GI was positively associated with the reduction in logHbA1c 
(0.003, 95%CI [0.001 to 0.006], p=0.006) overtime. The GI coefficient suggests that a 
one unit reduction in GI (in its original units of measurement) would result in a 0.3% 
decrease in HbA1c. Research suggests that a reduction as small as 1% in mean HbA1c 
can reduce risk of diabetes related complications. For example, a decrease of 21% for 
diabetes-related death, 14% for myocardial infarction and 37% for microvascular 
complications has been noted with a1% decrease in HbA1c [36].  Furthermore, since 
the relationship between HbA1c and diabetes related complications is continuous, any 
reduction in HbA1c would be beneficial [37]. There was no significant association found 
between GL and logHbA1c. Additionally, results suggest that as physical activity 
increased, HbA1c decreased.  
Fasting blood glucose 
There was no association between GI and fasting blood glucose overtime. 
However, when the relationship between fasting blood glucose and GI quartile was 
analyzed, a significant increase in fasting blood glucose was noted between the lowest 
quartile and the second lowest quartile. Additionally, results of that analysis suggest a 
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trend of increasing fasting blood glucose with increasing GI quartile.  No significant 
associations between GL and HbA1c or fasting blood glucose were found. 
The results of this study are subject to several limitations. First, dietary data were 
collected via self report. Second, 24-hour dietary recall was conducted in Spanish and 
translated by the assessor into English. Third, previous research suggests 
underreporting of dietary intake in Latino populations [38]. Fourth, all study participants 
were from Massachusetts, and thus represent a limited geographic range; all subjects 
were Latino, thus results may not be applicable to all racial and ethnic groups or those 
in other states. Finally, the majority of subjects were Puerto Rican. Previous research 
has suggested that variations exist between subgroups of Latinos and generalizations 
regarding Latinos as a single ethnic group should be made with caution.  
This study addressed several understudied yet important research questions that 
may help inform dietary recommendations for the treatment of T2D in low income Latino 
adults. This is the first study to assess GI and GL in a Latino population using repeated 
24 hour dietary recalls at multiple time points.  Results suggest that tailored 
interventions that target reducing GI and GL among Latinos with T2D can be effective, 
though changes were most pronounced in the short term. A reduction in GI was 
associated with a reduction in HbA1c. An association between a reduction in GL with a 
reduction in HbA1c was not evident. This study adds to the evidence suggesting that 
lowering dietary GI may enhance T2D glycemic control in among Latinos.  
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Table 1  
Latinos En Control Diabetes Self-Management (DSM) Curriculum: Session Objectives and Topics 
 
Session 
number 
Intensive Phase 
1 Rapport with patients; individual assessments of:  diabetes self management (DSM) history; DSM goals and 
incentives; expectations and commitment for the program; family support and resources for DSM; rationale 
for DSM; begin  
2 Group cohesiveness (i.e., icebreaking exercises); what is diabetes; meeting and working with a new health 
care provider; physical activity self-monitoring (step counters); begin walking and physical activity self-
monitoring.  
3 Attitudes toward healthy eating; healthiest foods (“Green” section of the Traffic Light Food Guide); 
communicating with dietitians; begin self-monitoring of food intake.  
4 Review of “Green” foods; portion control (“Yellow” section of the Traffic Light Food Guide); common 
challenges to self-monitoring of food intake.  
5 Review dietary concepts introduced up to now; behavior changes made up to now; foods to avoid or eat 
infrequently and in small amounts (“Red” section of the Traffic Light Food Guide); management of 
hypoglycemia and self-management; communicating with health care providers  
6 Mid-program review: physical activity, dietary concepts, self-monitoring, understanding and practice of self-
management for glucose control, management of hypoglycemia. 
7 Medication adherence; cholesterol and blood pressure; diabetes complications; barriers and resources to 
self-management; what to ask from health care providers. 
8 Foot care; infections; smoking; stress management; getting support from the health care system. 
9 Food labels and label reading skills; saturated fat, sodium and fiber. 
10 Food Shopping, Quick meals.  
11 Review food shopping strategies; heart healthy eating; management of sick days; following provider 
recommendations. 
12 Program review; future challenges to maintenance; keeping in touch with health care providers. 
 Maintenance Phase 
13 Review of self-management concepts; continuing to increase physical activity 
14 Progress toward healthy eating; new ideas for increasing healthiest foods; continuing to self-monitor self-
management behaviors; problem-solving challenges as a group.  
15 Managing challenges to portion control and avoiding unhealthy foods; Moving more. 
16 Review of self-management experiences. 
17 Medication adherence; cardiovascular risk factors and diabetes complications. 
18 Staying healthy and reducing stress. 
19 Future challenges to maintenance of behavior change. 
20 Review and graduation  
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Table 2  
Baseline Characteristics (mean and percentages) by Quartile of Glycemic Index and Glycemic Load  
 Quartile dietary GI Quartile dietary GL 
 1(lowest) 2 3 4(highest)  1(lowest) 2 3 4(highest)  
N 59 60 59 60 p 59 60 59 60 p 
Range 
46.58-     
58.23 
58.24-  
60.99 
61.00-  
64.32 
64.33-
76.02 
 
30.14- 
95.40 
95.41-    
119.99 
120.20-   
151.88 
151.89-   
299.42 
 
Intervention Group 38.98       50.00       49.15       56.67 0.284 45.76       50.00       50.85       48.33 0.949 
Glycemic Index na na na na  59.06 60.63 61.64 62.56 0.001 
Glycemic Load 111.04 122.68 129.72 143.36 0.002 na na na na  
Age (yrs) 56.56 57.15 56.42 52.6 0.101 59.10 58   54.22 51.42 P<.001 
Gender ( % Female) 76.27       80.00       81.36       71.67 0.588 89.83       78.33       72.88       68.33 0.033 
Medication Intensity 
Score 
2.92 2.92 2.71 3.11 0.660 2.99 3.05 2.864 2.77 0.804 
Physical Activity 12.02 13.32 11.06 13.99 0.068 12.69 11.88 12.29 13.61 0.524 
Marital Status (%)           
Not married 63.79       56.90       63.79       54.24 0.631 70.69       62.71       52.54          52.63 0.134 
Income (%)           
<10,000$ 50.94       64.15       54.90       52.00  52.00       64.81       54.72       50.00  
10,000-20,000$ 43.40       26.42       37.25       40.00  40.00       29.63       37.74       40.00  
>20,000$ 5.66        9.43        7.84        8.00 0.697 8.00        5.56        7.55       10.00 0.815 
Education (%)           
<= high school 76.27       81.67       76.27       70.00 0.523 74.58       80.00       77.97       71.67 0.721 
Family history of DM           
Yes 81.03       86.44       79.31       84.75 0.721 81.36       79.66       83.05       87.72 0.689 
HbA1c  (%) 8.23 9.35 9.04 9.20 0.005 8.74 8.82 9.20 9.07 0.511 
FBG (mmol/L) 152.36 173.30 172.49 175.50 0.241 163.06 163.88 173.53 173.37 0.754 
BMI (kg/m) 34.60 35.06 35.29 34.24 0.847 34.94 33.08 35.01 36.20 0.100 
Waist circumference (cm) 110.67 112.22 113.30 111.24 0.749 110.46 107.98 113.14 115.93 0.012 
Mean Arterial Pressure 
(mm/Hg) 
96.18 98.62 96.03 95.09 0.380 97.18 98.25 95.23 95.26 0.391 
Total cholesterol (mg/dl) 180.24 177.67 183.05 181.67 0.926 193.61 170.25 177.78 181.12 0.036 
HDL cholesterol (mg/dl) 44.24 43.23 44.66 44.43 0.829 46.64 43.88 42.93 43.12 0.086 
LDL cholesterol (mg/dl) 106.53 103.52 104.43 108.86 0.867 119.63 98.56 100.21 104.97 0.007 
VLDL cholesterol 
(mg/dl) 
27.59 30.22 28.20 28.14 0.751 27.31 27.39 29.29 30.21 0.602 
Triglyceride (mg/dl) 153.73 162.60 162.78 145.12 0.787 142.47 141.42 177.36 163.03 0.214 
Total Energy (kcal) 1640.12 1683.05 1711.07 1767.84 0.665 1091.57 1513.56 1856.21 2334.01 P<.001 
Total Carbohydrate 
(grams) 
221.87 221.13 221.40 227.24 0.971 137.25 192.75 236.30 324.19 P<.001 
Total Fiber (grams) 17.36 15.19 14.21 13.54 0.005 10.91 14.50 14.83 19.95 P<.001 
Soluble Fiber (grams) 4.95 4.67 4.41 4.12 0.165 3.24 4.34 4.489 6.06 P<.001 
Insoluble Fiber (grams) 12.19 10.37 9.64 9.33 0.002 7.62 10.02 10.21 13.62 P<.001 
Total Fat (grams) 51.53 58.31 59.68 64.24 0.050 37.32 51.45 66.45 78.42 
 
P<.001 
Saturated fat (grams) 17.07 18.49 19.59 19.03 0.411 12.11 16.46 21.40 24.16 P<.001 
Trans fatty Acids 2.21 2.95 3.18 3.21 0.015 1.802 2.62 3.30 3.82 P<.001 
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Table 3 
Multivariate Random Effects Analyses of the Relationship between Glycemic 
Index and Glycemic Load with Glycemic Control 
Glycemic Index and logHbA1c n=560 
Covariate Coef. 95% CI P>|z| 
Glycemic Index  0.003 0.001 to 0.006 0.009 
Lipid lowering drugs -0.031 -0.057 to -0.004 0.022 
Age  -0.004 -0.007 to -0.002 <0.001 
BMI -0.004 -0.007 to -0.001 0.005 
Physical activity  -0.004 -0.006 to -0.002 <0.001 
Medication Intensity Score 0.024 0.014 to 0.035 <0.001 
Arm -0.046 -0.089 to -0.002 0.041 
Time  -0.025 -0.038 to -0.012 <0.001 
Constant 2.381 2.141 to 2.620 <0.001 
Glycemic Index and Fasting Blood Glucose n=560 
Glycemic Index  0.736 -0.237 to 1.710 0.138 
Lipid lowering medication -10.680 -20.324 to -1.037 0.030 
Age -1.937 -2.573 to -1.300 <0.001 
BMI -1.485 -2.433 to -0.536 0.002 
Physical activity  -1.095 -1.931 to -0.259 0.010 
Medication Intensity Score 4.909 1.226 to 8.592 0.009 
Constant 284.735 200.255 to 369.215 <0.001 
Glycemic Load and logHbA1c n=562 
Glycemic Load  0.000 -0.000 to 0.001 0.189 
Lipid decreasing drugs -0.032 -0.059 to -0.005 0.020 
Medication Intensity Score 0.023 0.012 to 0.033 <0.001 
Physical activity  -0.003 -0.005 to -0.001 0.005 
Arm -0.055 -0.100 to -0.009 0.018 
Time  -0.025 -0.039 to -0.012 <0.001 
Constant  2.149 2.076 to 2.222 <0.001 
Glycemic Load and Fasting Blood Glucose n=560 
Glycemic Load  0.035 -0.097 to 0.166 0.604 
Lipid decreasing drugs -11.028 -20.703 to -1.353 0.025 
Medication Intensity Score 4.900 1.200 to 8.601 0.009 
BMI -1.457 -2.409 to -0.505 0.003 
Age -1.949 -2.594 to -1.304 <0.001 
Physical activity  -1.105 -1.943 to -0.267 0.010 
Constant 325.220 262.341 to 388.098 <0.001 
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Figure 1 Participant Flow Diagram 
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Figure 2  
Change  within Glycemic Index Quartile from Baseline to 4 Months and 12 Months by Baseline Glycemic 
Index and Treatment Condition 
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Figure 3 
 Change within Glycemic Load Quartile from Baseline to 4 Months and 12 Months by Baseline Glycemic 
Load and Treatment Condition 
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Chapter III 
The Association between Glycemic Index, Glycemic Load and Lipid Profiles 
among Low-income Latinos with Type 2 Diabetes 
 
Abstract 
Background 
Cardiovascular disease is the leading cause of mortality in individuals with type 2 
diabetes and these individuals often have earlier presentation of cardiovascular disease 
than individuals without diabetes. Thus, reduction in cardiovascular disease risk factors 
in individuals with type 2 diabetes would be beneficial. While studies suggest the 
beneficial effect of reducing dietary glycemic index and glycemic load on diabetes 
control in patients with type 2 diabetes, little clinical data exists regarding the effect on 
blood lipids.  
Purpose 
The purpose of this study was to determine the effect of changes in glycemic index and 
glycemic load on lipid profiles determined by high density lipoprotein (HDL) cholesterol, 
low density lipoprotein (LDL) cholesterol, total cholesterol (TC), TC: HDL ratio, HDL:LDL 
ratio and triglyceride levels among low-income Latino individuals with type 2 diabetes. 
Methods 
Latino patients with type 2 diabetes participated in a 12 month randomized clinical trial 
testing the efficacy of a diabetes self-management intervention. The group-based 
intervention targeted diabetes knowledge, attitudes and behavioral capabilities and its 
content was tailored to the cultural and literacy needs of the population. Measurements 
were collected at baseline, 4 and 12-month follow-up and included three 24-hour dietary 
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recalls, a fasting blood sample, clinical assessments, and demographic and 
psychosocial interviews at each time points. Multivariate random effects analyses were 
used to test the association between GI and GL with lipid profiles overtime. 
Results 
A total of 252 Latino adults with type 2 diabetes participated in the study. The baseline 
mean (SD) HbA1C was 8.98% (±1.87), age was 56 (±11.2) years, 76 % were female. A 
reduction in glycemic index was positively associated with improvement in HDL:LDL 
ratio (P=0.05), but not with levels of HDL, LDL, TC, or triglyceride levels. No significant 
associations between glycemic load and any lipid outcomes were observed.  
Conclusion 
While the results of this study suggest a benefit of lowering glycemic index on one 
marker of the lipid profile, no beneficial effect of lowering glycemic index was noted for 
the majority of lipid profile markers and results showed no beneficial effect of lowering 
glycemic load on lipid profiles.  
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INTRODUCTION 
The incidence of T2D has increased at a dramatic rate over the past several 
decades [13] and Latinos suffer higher rates of T2D. Results of a recent study suggest 
that the combined crude prevalence of diagnosed and undiagnosed diabetes is 80% 
higher in Mexican Americans compared to non-Latino whites after controlling for age 
and gender [1]. Latinos have high rates of uncontrolled T2D [2, 13] which fosters long-
term microvascular complications and an eventual increase in macrovascular 
complications including CVD [3]. Thus, reduction in CVD risk factors in individuals with 
T2D would be beneficial.  
Various causal factors for the increased CVD risk in patients with T2D have been 
posited including genetics, hyperglycemia, obesity, hypertension and dyslipidemia. The 
prevalence of dyslipidemia is high in patients with T2D [39-41] and typically these 
patients have fasting hypertriglyceridaemia and postprandial lipemia. Potential 
physiological pathways by which dyslipidemia may cause diabetic vascular 
complications and disease have been well studied [42-48]. Multiple theories have been 
reported such as: increased oxidative stress, vascular inflammation, insufficient or 
altered actions of insulin, hormones, and inflammatory cytokines [42, 43, 47].  
In healthy individuals, blood glucose level is tightly maintained by homeostatic 
regulatory systems. However, the physiological effects of ingestion of high glycemic 
foods challenge these mechanisms.  The rapid increase in blood glucose following 
consumption of a high glycemic index meal stimulates insulin release and inhibits 
glucagon release to a much greater extent than after consumption of a low glycemic 
index meal. This results in exaggerated glucose uptake by skeletal muscle, storage of 
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fat, and inhibition of fat breakdown. The major metabolic fuels (glucose oxidation and 
free fatty acids) are suppressed. Nutrient absorption from the gastrointestinal tract then 
declines while the biological effects of insulin release and glucagon suppression persist, 
resulting in a rapid fall in blood glucose levels, often into the hypoglycemic range. The 
low levels of metabolic fuels trigger a counter-regulatory hormone response, increasing 
free fatty acids, and creating a fasting physiological state. Research to date suggests 
that stimulation of these exaggerated physiological responses repeatedly over time may 
promote excessive food intake, beta cell dysfunction, dyslipidemia, and endothelial 
dysfunction; increasing risk for CVD [17]. 
Results of observational studies suggest a beneficial effect of lower GI and GL 
diets on lipid profiles including triacyglycerol levels and HDL  [49-53]. However, few 
experimental studies have investigated the effect of reducing dietary GI and GL on lipid 
profiles in patients withT2D, and no study has investigated the effects of lowering GI 
and GL in Latinos. Given that Latinos have a high prevalence of T2D and that 
consumption of low GI or low GL foods may result in improved lipid profiles, an 
examination of the quantity and quality of carbohydrate intake among Latinos with T2D, 
and the association between GI and GL and clinical endpoints, may have great public 
health implications. The purpose of this study was to determine the effect of GI and GL 
on lipid profiles among low-income Latino individuals with T2D. 
 
Methods 
Study Participants 
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Patients with T2D were recruited from five community health centers (CHC) in 
urban areas of central and western Massachusetts.  At each CHC, a trained site 
research coordinator overseen by the research team was responsible for completing the 
recruitment processes. Subjects were included if they: were diagnosed with T2D;had an 
HbA1c level > 7.5; were currently  being treated with diet, oral hypoglycemics or insulin 
and, if they were currently on insulin, they must have had a history of prior therapy with 
diet alone or oral hypoglycemic agents; were Latino origin; were > 18 years old; had a 
telephone in home or easy access to one;  were able to understand and participate in 
the study protocol and functionally capable of meeting the physical activity goals; 
understood and could provide informed consent; and were given physician approval to 
participate in the study. Subjects were excluded if they: had a history of diabetic 
ketoacidosis; current gestational diabetes; were unable or unwilling to provide informed 
consent; had any plans to move out of the area within the 12-month study period; 
required intermittent glucocorticoid therapy within the past 3 months; experienced an 
acute coronary event within the previous 6 months or had any medical condition that 
precluded adherence to study dietary recommendations or had any major psychiatric 
illness.   
Determination of subject eligibility and recruitment was conducted in several 
stages. First, health care providers at participating CHCs were notified of the study and 
their approval for the site research coordinator to access patient medical records for 
screening purposes was obtained. Second, a review of the medical records of 
potentially eligible patients’ was completed. For patients determined to be medically 
eligible to participate, approval and a signature on the recruitment letter was obtained 
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from their primary care physician. Third, a letter describing the study was mailed to the 
patients who received primary care physician approval. Prior to participation in the study 
written informed consent was obtained from all participants. Once the baseline 
assessment was completed, participants were randomized to either the usual care 
condition or to Latinos En Control intervention condition. Randomization was completed 
at the level of the individual and stratified by CHC site, gender, baseline HbA1c levels 
and insurance status. Within each strata, participants were randomized in randomly 
allocated blocks of size 2, 4 and 6 using a reallocation program [30] version 7.0 (Stata 
Corporation, College Station, TX). Block randomization was used to ensure blinding of 
the allocation sequence. The study protocol was approved by the University of 
Massachusetts Medical School’s and the Baystate Medical Center’s Institutional Review 
Boards. 
Intervention 
Participants in the intervention condition, Latinos en Control, participated in a one 
year, group based intervention, consisting of two phases: an intensive phase with 12 
weekly sessions followed by a maintenance phase with 8 monthly sessions. An outline 
of the self-management curriculum is presented in Table 1. The intervention targeted 
diabetes knowledge (e.g., effect of foods of different GI on diabetes control), attitudes 
(e.g., self-efficacy for dietary change) and behavioral capabilities (i.e., skills needed to 
make lifestyle changes) with its content tailored to the cultural and literacy needs of this 
population.  Personalized coaching was offered during 10-minute counseling segments 
prior to the start of each group.  
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The dietary component of the intervention used the metaphor of a traffic light to 
simplify complex concepts. Foods frequently consumed by Latinos were classified 
based on their GI, fat, salt, and fiber content into categories of “green”, “yellow,” or “red” 
foods. A “food guide” which included pictures of these foods within the corresponding 
“traffic light colors” was developed and provided to all participants. Additionally, 
participants were given a graphic of a plate which displayed the ideal balance of colors 
at any given meal. Explained simplistically, the color green classified recommended 
foods which were lower in calories, saturated or trans-fat and sodium content and were 
of lower GI.  “Yellow” foods were medium in calories, saturated or trans-fat and sodium 
content and were of medium GI.  “Red” foods were higher in calories, saturated or 
trans-fat and sodium content and were of higher GI. To impact GL, reduction of portion 
sizes was emphasized and all participants received a set of measuring cups. Subjects 
participated in multiple interactive sessions including: healthy cooking methods for 
ethnic foods, label reading, a supermarket tour, group meals where measuring cups 
were used for modeling appropriate portion sizes and guided discussions explored taste 
and appeal of the foods, the ease of preparation, and strategies to incorporate new 
cooking methods at home. Participants were provided with and instructed in the use of 
glucose meters and step counters.  
Usual care was defined as diabetes care as currently delivered at the CHC. 
Therefore, participants in the usual care group received medical therapy as determined 
to be appropriate by their healthcare providers. Healthcare providers received all 
laboratory reports for all participants regardless of their study condition. 
Measurement 
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Measurements were collected at baseline, 4 and 12-month follow-up and 
included three 24-hour recalls, clinical assessments, and demographic and 
psychosocial interviews at each time point. Dietary intake and physical activity [31] were 
assessed via three unannounced telephone administered 24-hour recalls. Multiple 
recalls are used to assess day-to-day intra-individual variations in the behaviors of 
interest [32]. The Minnesota Nutrition Coordinating Center’s (UM-NCC) Nutrition Data 
System for Research software (NDS-R) was used to collect and analyze the 24-hour 
dietary recall data [33].  At each assessment visit, fasting blood samples were drawn for 
analysis of TC, LDL, HDL and triglycerides, fasting glucose, and HbA1c.  Body Mass 
Index (BMI) was calculated as weight in kg divided by height in cm². Weight was 
assessed with a Tanita BWB800S Digital Physicians Scale and Height was asses with a 
Seca Road Rod Portable Stadiometer.  Waist circumference was measured in 
centimeters to 0.1 cm.  Waist circumference was measured twice and the mean value 
was used in the analyses. Two blood pressure measurements were taken using a 
Dinamap XL automated BP monitor.  All medications and supplements were recorded. 
Demographic and additional data were collected via self-reported survey, including; 
age, gender, education level, and duration of diabetes. In order to account for the 
potential effect of medications on blood glucose, lipids, and weight, two pharmacists 
compiled the medication used by study participants based on whether they had a 
positive or adverse effect on these outcomes. In addition, glucose lowering agents were 
combined to construct a diabetes medication intensity score. This score was based on 
the type of oral hypoglycemics taken and/or dose and type of insulin taken. Possible 
scores ranged from 0- 6.5, with a higher score equating to greater number or dose of 
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medication/insulin. Participants were compensated with 30 dollars at each assessment 
timepoint.  
 
Statistical Analysis 
 
All analyses were performed using STATA version 11. (StataCorp, College 
Station, TX) Results are expressed as means with 95% confidence intervals (CIs). 
Descriptive statistics were calculated for continuous covariates (age, BMI, physical 
activity, blood pressure, medication score), exposure variables (GI, GL), and outcomes 
(HDL, LDL, TC, TC:HDL ratio, HDL:LDL ratio and triglyceride). The natural logarithm of 
triglycerides was used in the multivariate analyses because the distribution was 
skewed. Although GI and GL were continuous variables, for univariate statistical 
inferences, baseline demographic and clinical data were stratified by baseline GI and 
GL quartile and compared differences by Chi-Square or ANOVA tests.   
          Four separate random effects models were developed with either the outcome 
being HDL cholesterol, LDL cholesterol, total cholesterol, HDL:LDL ratio and log 
triglyceride and the primary predictor of interest being the exposure variable of GI or GL 
(ie, a model examining the effect of GI on HDL adjusted for other confounders, followed 
by a model examining GL on HDL and then repeated for LDL, TC, TC:HDL ratio, 
HDL:LDL ratio and log triglyceride. Each model was controlled for age, gender, mean 
arterial blood pressure, total energy intake, physical activity, diabetes medication 
intensity score, lipid increasing and decreasing drugs, and weight increasing and 
decreasing drugs and study arm. A backward elimination process was used for each 
model, until only significant variables remained. Additionally, linear regression was used 
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to determine the association between change in glycemic index and glycemic load with 
change in HDL, LDL, TC, HDL:LDL ratio, TC:HDL ratio and log triglyceride from 
baseline to 4 months follow-up.  
The primary multivariate analysis was a complete case analysis in which patient 
records with missing values were not in the regression models.  To investigate the 
potential effect of missing data, two imputed sensitivity analyses were completed. The 
first analysis was intention to treat analysis, which included all 252 randomized 
participants, with the baseline observation carried forward when missing values were 
present. The second method relied on multiple imputation by chained equations (MICE) 
analysis [34]. No differences were found between the analyses. Thus, results using 
complete data are presented herein. 
 
 
RESULTS 
Baseline Characteristics 
The participant flow diagram is shown in Figure 1. A total of 252 Latino adults 
with T2D participated in the study. Although all lipid outcomes were continuous 
variables in these analyses, for purposes of baseline inference, baseline demographic 
and clinical data were stratified by baseline HDL, LDL and TC (see Table 2a). The 
baseline mean (SD) HbA1C was 8.98 % (±1.87), age was 56 (±11.18) years, 76 % were 
female. There was a significant difference in HDL, LDL and TC quartile by gender. 
Significantly more females were in the highest quartile for HDL, LDL and TC compared 
to men. There was a significant difference in Hba1c and fasting blood glucose by 
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quartile of LDL and TC but not HDL. Those in the highest quartile of LDL had 
significantly higher HbA1c and fasting blood glucose levels compared to those in the 
lower quartiles. Additionally there was a significant difference in waist circumference by 
HDL. 
Change in GI and GL  
A significant reduction (baseline minus 4 month value) in mean GI was seen in the 
treatment group at 4 months (treatment -2.57 (7.25) vs. control 0.87 (5.95), p<0.001).  
However, while this trend remained, the difference between conditions was no longer 
statistically significant at 12 months (treatment -0.63 (7.15) vs. control 0.42 (5.96) vs., 
p=0.27). A significant reduction in mean GL was seen in the treatment group compared 
to the control group at 4 months (treatment -20.42 (46.87) vs. control 7.41 (44.12), p 
<0.001), and at 12 months (treatment-14.62 (46.82) vs. control 6.48(43.15), p <0.001).   
There was no statistically significant association between change in glycemic index or 
glycemic load with change in HDL, LDL, TC, HDL;LDL ratio, TC:HDL ratio or log 
triglycerides from baseline to 4 months follow up.  
Overall Association of Glycemic Index and Lipid Profiles 
Table 3a and Table 4a illustrate the results of the multivariate longitudinal 
random effects model analyses. A reduction in GI was positively associated with 
improvement in HDL:LDL ratio (0.003, 95%CI [0.000 to 0.006], p=0.039) overtime, but 
not with individual lipid markers: HDL, LDL, TC or log triglycerides (-0.026, 95%CI [ -
0.121 to 0.060] p=0.597, and (-0.011, 95%CI [ -0.42 to 0.40] p=0.96, and -0.04, 95%CI [ 
-0.53 to 0.46] p=0.88,and 0.002, 95%CI [-0.005 to 0.008], p=0.58, respectively) or 
TC:HDL ratio 0.01, 95%CI[-0.005 to 0.024], p=0.21 over time.  
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Overall Association of Glycemic Load and Lipid Profiles 
No significant associations between GL and any lipid outcomes were found (TC 
0.03, 95%CI[-0.04 to 0.12],p=0.36, and HDL -0.001, 95%CI[-0.015 to 0.012], p= 0.826, 
and LDL 0.03, 95%CI[-0.03 to 0.09],p=0.28, and HDL:LDL ratio 0.00, 95%CI[-0.00 to 
0.00],p=0.62 and TC:HDL ratio 0.00, 95%CI [-0.001 to 0.003], p=0. 262 and log 
triglycerides 0.00 , 95%CI[-0.00 to 0.00],p=0.08) overtime.  
DISCUSSION 
The results of this study showed that a reduction in GI was positively associated 
with improvement in HDL:LDL ratio, although this improvement was moderate. The 
utility of HDL:LDL ratio for prediction of CVD risk has been debated. Since the impact of 
increased LDL and decreased HDL on CVD risk is well established, it has been 
suggested that the HDL:LDL ratio is a good measure of atherosclerosis risk [54, 55]. 
However, others have suggested that absolute values of HDL and LDL are more 
accurate predictors and are better suited for clinical practice. A patient’s HDL:LDL ratio 
should be above 0.3%, ideally being above 0.4%. In our sample the mean HDL:LDL 
ratio at baseline was 0.47% with mean HDL 44.3 mg/dl and LDL 106.6 mg/dl. Thus at 
baseline, on average, participants had low HDL and borderline normal LDL levels, just 
as previous research has suggested.  
No significant associations between GI with HDL or LDL, TC, TC:HDL ratio or 
triglycerides over time were noted and no significant associations between GL and any 
lipid outcome over time were found. One possible explanation for the lack of effect of GI 
and GL on HDL or LDL, TC or triglycerides is that the decrease in GI and GL may not 
have been clinically significant. The absolute reduction in both GI and GL was very 
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small (at 4 months treatment -2.57 (7.25) vs. control 0.87 (5.95), p<0.001 and at 12 
months treatment -0.63 (7.15) vs. control 0.42 (5.96) vs., p=0.27). Greater reductions in 
GI and GL might be needed to see a significant change in lipid levels. However, as this 
population had a relatively low mean baseline GI (61, glucose reference) greater 
reductions may be difficult to achieve.   
Another possible explanation for the lack of effect may be the physiological 
pathway in which changes in GI and GL impact lipid outcomes. If the primary pathway is 
through a reduction in hyperglycemia or hyperinsulinemia, changes in these markers 
would need to occur before significant changes in lipids would be observed. Analyses of 
glycemic control in this sample showed a beneficial effect of lowering GI on HbA1c but 
not fasting glucose levels, and only in the short term (see chapter 3). Markers of 
hyperinsulinemia were not assessed. Thus, it is plausible that in this sample decreases 
in blood glucose levels or insulin levels were not great enough to have an impact on all 
but one lipid marker.  
Similar to our findings, several previous studies have reported beneficial effects 
of lowering GI on one or two lipid markers, but not others. Several studies have shown 
improvements in HDL or LDL and TC [6, 8, 9, 26, 29, 56-58] while no studies showed 
an improvement in triglycerides and one study showed no improvement in any lipid 
marker [6]. Furthermore, results of recent meta-analyses of the effect of low GI diets on 
markers of CVD risk were inconsistent [59, 60]. One meta analysis reported that low GI 
diets had beneficial effects on LDL and TC but not on HDL or triglycerides among adults 
with T2D [60]. While another showed no beneficial effect of low GI diets on LDL or HDL, 
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or triglyceride level and weak evidence for reductions in TC [59]. Neither review 
included any studies which assessed the effect of GI on TC:HDL ratio or HDL:LDL ratio.  
A one year randomized clinical trial Wolever et al. (2008) [10] assessed the effect 
of a  low GI dietary intervention compared to either a high GI or a low- carbohydrate 
dietary intervention in well-controlled individuals with T2D. One hundred and sixty two 
subjects participated in a multicenter trial in which the impact of the three diets on 
glycemic control assessed by HbA1c, blood glucose, lipids, and C-reactive protein were 
assessed. The results suggested a significant difference in TC:HDL but not HDL, LDL, 
triglycerides and TC [10]. Only one study has previously investigated the effect of 
lowering GI in Latino subjects with T2D. Jimenez-Cruz et al. [28] conducted a 6-week 
crossover feeding study in which 14 overweight and obese Mexicans with T2D were 
given a low-GI diet, containing Mexican-style foods and then a high GI diet. The results 
showed no significant differences in TC, HDL or LDL, or triglycerides between the two 
dietary conditions. To our knowledge no clinical trial has assessed the effects of 
lowering GL on lipid outcomes.  
The results of this study are subject to several limitations. First, dietary data were 
collected via self report. Previous research suggests underreporting of dietary intake in  
Latino populations [38]. Second, 24-hour dietary recalls were conducted in Spanish and 
translated by the assessor into English. Third, all study participants were from 
Massachusetts and thus represent a limited geographic range and all subjects were 
Latino, thus results may not be applicable to all racial and ethnic groups or those in 
other states. Finally, the majority of subjects were Puerto Rican. Previous research has 
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suggested that variations exist between subgroups of Latinos thus generalizations 
regarding Latinos as a single ethnic group should be made with caution.  
Implications for future research 
Hypotheses regarding the physiological pathway by which reduction in GI and GL 
may impact lipids have been suggested. However, it remains unclear why reduction in 
GI and GL would impact some lipids and not others. Previous research has highlighted 
alterations in lipid quantity and quality among patients with diabetes. It is possible that 
lowering GI and GL could have beneficial effects on qualitative features of lipid particles, 
such as LDL size, thus further research in this area is warranted. Furthermore, several 
studies have shown that lowering GI and GL can improve markers along the causal 
pathway. For example, Pittas et al. [25] showed that a moderate decline in C-reactive 
protein, a marker for low-level inflammation, has been associated with lower GI/GL 
diets. However, another study showed no association between GI, GL and CRP [61]. 
Reduction in GL has been associated with improvements in plasminogen activator 
inhibitor- 1, a measure of procoagulant activity [62]. Future research should address the 
possible effects of GI and GL on variables along hypothesized causal pathways, such 
as oxidative stress and vascular inflammation. CVD is the leading cause of mortality in 
individuals with T2D. Thus, reduction in CVD risk factors in individuals with T2D would 
be beneficial. Similar to the results of previous research, the results of this study were 
inconsistent. Further research on the effects of GI and GL on lipid outcomes is 
warranted.  
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Table 1a 
Latinos En Control Diabetes Self-Management (DSM) Curriculum: Session Objectives and Topics 
 
Session 
number 
Intensive Phase 
1 Rapport with patients; individual assessments of:  diabetes self management (DSM) history; DSM goals and 
incentives; expectations and commitment for the program; family support and resources for DSM; rationale 
for DSM; begin  
2 Group cohesiveness (i.e., icebreaking exercises); what is diabetes; meeting and working with a new health 
care provider; physical activity self-monitoring (step counters); begin walking and physical activity self-
monitoring.  
3 Attitudes toward healthy eating; healthiest foods (“Green” section of the Traffic Light Food Guide); 
communicating with dietitians; begin self-monitoring of food intake.  
4 Review of “Green” foods; portion control (“Yellow” section of the Traffic Light Food Guide); common 
challenges to self-monitoring of food intake.  
5 Review dietary concepts introduced up to now; behavior changes made up to now; foods to avoid or eat 
infrequently and in small amounts (“Red” section of the Traffic Light Food Guide); management of 
hypoglycemia and self-management; communicating with health care providers  
6 Mid-program review: physical activity, dietary concepts, self-monitoring, understanding and practice of self-
management for glucose control, management of hypoglycemia. 
7 Medication adherence; cholesterol and blood pressure; diabetes complications; barriers and resources to 
self-management; what to ask from health care providers. 
8 Foot care; infections; smoking; stress management; getting support from the health care system. 
9 Food labels and label reading skills; saturated fat, sodium and fiber. 
10 Food Shopping, Quick meals.  
11 Review food shopping strategies; heart healthy eating; management of sick days; following provider 
recommendations. 
12 Program review; future challenges to maintenance; keeping in touch with health care providers. 
 Maintenance Phase 
13 Review of self-management concepts; continuing to increase physical activity 
14 Progress toward healthy eating; new ideas for increasing healthiest foods; continuing to self-monitor self-
management behaviors; problem-solving challenges as a group.  
15 Managing challenges to portion control and avoiding unhealthy foods; Moving more. 
16 Review of self-management experiences. 
17 Medication adherence; cardiovascular risk factors and diabetes complications. 
18 Staying healthy and reducing stress. 
19 Future challenges to maintenance of behavior change. 
20 Review and graduation  
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Table 2a 
Baseline Characteristics (mean and percentages) by Quartile of HDL Cholesterol, LDL Cholesterol and Total 
Cholesterol 
 Quartile HDL Cholesterol  Quartile LDL Cholesterol 
 1 2 3 4 p 1 2 3 4 p 
range 25-37 38-42 43-49 50 -84  18-80 81-102 103-125 126-258  
n 61 63 62 66  60 61 62 61  
Intervention Group 44.26 52.38 51.61 48.48 0.80 50.00 40.98 50.00 57.38 0.35 
Glycemic Index 60.47 61.29 61.32 60.80 0.76 60.52 61.24 61.04 61.09 0.89 
Glycemic Load 134.32 125.99 127.27 119.65 0.41 136.52 118.46 126.94 125.15 0.24 
Age (yrs) 54.44 57.97 55.66 55.79 0.36 56.95 55.74 56.55 54.92 0.76 
Gender (%) (Female) 54.10 80.95 79.03 90.91 P<.001 60.00 77.05 85.48 85.25 0.00 
Medication Score 2.80 2.873 2.85 3.11 0.74 2.95 2.74 3.10 2.950 0.70 
Physical Activity 13.02 12.76 12.31 12.37 0.93 12.10 14.34 11.93 11.963 0.13 
Marital Status (%) (NM) 54.10 66.13 53.33 69.84 0.14 50.85 61.67 72.41 59.02 0.12 
Income ($)    <10,000 52.83 62.30 53.06 51.85  59.18 55.77 52.73 54.72  
10,000-20,000 32.08 31.15 42.86 42.59  34.69 36.54 40.00 35.85  
>20,000 15.09 6.56 4.08 5.56 0.28 6.12 7.69 7.27 9.43 0.99 
Education ( <= high school) 72.13 73.02 75.81 80.30 0.70 76.67 75.41 77.42 72.13 0.91 
HbA1c  (%) 9.14 8.80 8.77 9.21 0.43 8.65 8.88 8.88 9.53 0.05 
FBG (mmol/L) 175.60 160.29 164.47 174.48 0.56 151.00 163.92 169.74 190.57 0.02 
BMI (kg/m) 34.73 34.62 36.19 33.58 0.21 33.73 35.55 36.05 33.64 0.12 
Waist Circumference 112.03 111.15 115.84 107.93 0.01 110.72 112.90 114.14 108.93 0.17 
Mean Arterial Pressure(mm/Hg) 96.23 96.76 96.08 96.87 0.97 96.35 95.98 95.17 98.61 0.39 
Total Cholesterol 166.45 181.94 175.08 201.23 P<.001 133.00 161.95 185.21 236.85 P<.001 
HDL Cholesterol na na na na  42.75 43.18 44.15 47.85 0.01 
LDL Cholesterol 95.71 106.77 103.47 119.00 0.01 na na na na  
Triglyceride 198.84 174.14 129.76 123.91 P<.001 128.78 135.67 140.68 160.74 0.07 
Total Energy (kcal) 1820.7
3 
1682.90 1663.91 1639.68 0.31 1813.06 1618.74 1663.49 1693.49 0.30 
Total Carbohydrate 256.42 247.60 232.00 236.89 0.77 244.42 206.51 221.93 218.92 0.08 
Total Fiber 16.33 15.46 14.75 13.78 0.15 17.56 13.99 14.55 14.18 0.01 
Total Fat 63.81 57.00 56.33 56.89 0.32 60.20 57.28 56.59 58.51 0.88 
Saturated Fat 19.73 17.98 18.10 18.41 0.67 18.68 18.66 18.37 18.15 0.99 
Trans fatty Acids 3.09 2.79 2.83 2.84 0.84 2.69 3.00 2.83 2.96 0.83 
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Table 3a 
Multivariate Random Effects Analyses of the Relationship between Glycemic Index  
with Lipid Profiles 
Glycemic Index and Total Cholesterol  
Covariate  Coef. 95% CI P>|z| 
Glycemic Index  -0.04 -0.53 to 0.46 0.88 
Gender -14.90 -27.21 to -2.60 0.02 
Lipid lowering drugs -31.75 -38.59 to -24.90 <0.001 
BMI -0.87 -1.54 to -0.20 0.01 
Mean arterial pressure 0.33 0.07 to 0.58 0.01 
Physical activity -0.48 -0.93 to -0.02 0.04 
Constant  n=560 225.39 176.74 to 274.05 <0.001 
Glycemic Index and HDL Cholesterol  
Glycemic Index  -0.03 -0.13 to 0.07 0.55 
Gender -6.39 -8.78 to -4.00 <0.001 
Physical activity 0.08 0.03 to 0.13 0.002 
Constant  n=622 46.66 38.88 to 54.43 <0.001 
Glycemic Index and LDL Cholesterol  
Glycemic Index  -0.01 -0.42 to 0.40 0.96 
Gender -12.51 -22.68 to -2.34 0.02 
Lipid lowering drugs -27.89 -33.53 to -22.25 <0.001 
BMI -0.73 -1.27 to -0.18 0.01 
Constant  n=547 164.08 129.84 to 198.31 <0.001 
Glycemic Index and Total Cholesterol:HDL Cholesterol Ratio 
Glycemic Index   0.01 -0.005 to 0.024 0.210 
Lipid lowering drugs -0.77 -0.960 to -0.572 <0.001 
Constant n=568 4.06 3.168 to 4.957 <0.001 
Glycemic Index and HDL:LDL Cholesterol Ratio  
Glycemic Index 0.003 0.000 to 0.006 0.039 
Lipid lowering drugs 0.125 0.088 to 0.162 <0.001 
Time  0.016 0.001 to 0.030 0.036 
Constant n=549  0.214 0.044 to 0.384 0.014 
    
Glycemic Index and Log Triglycerides 
Glycemic Index  0.00 -0.01 to 0.01 0.58 
Lipid lowering drugs -0.12 -0.21 to -0.04 0.01 
Age -0.01 -0.02 to -0.00 0.003 
Physical activity -0.01 -0.02 to -0.00 0.004 
Constant  n=562 5.43 4.89 to 5.98 <0.001 
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Table 4a 
Multivariate Random Effects Analyses of the Relationship between Glycemic Load  
with Lipid Profiles 
Glycemic Load and Total Cholesterol  
Covariate  Coef. 95% CI P>|z| 
Glycemic Load  0.03 -0.04 to 0.11 0.36 
Gender -15.80 -28.26 to -3.35 0.01 
Lipid lowering drugs -31.99 -38.85 to -25.13 <0.001 
BMI -0.89 -1.56 to -0.22 0.01 
Mean arterial pressure 0.33 0.07 to 0.59 0.01 
Physical activity -0.47 -0.93 to -0.02 0.04 
Constant  n=560 220.44 180.25 to 260.63 <0.001 
Glycemic Load and HDL Cholesterol  
Glycemic Load  -0.001 -0.015 to 0.012 0.826 
Gender -6.402 -8.810 to -3.993 <0.001 
Mean arterial pressure 0.082 0.033 to 0.131 0.001 
Time  0.593 0.113 to 1.073 0.016 
Constant n= 622  44.183 38.584 to 49.782 <0.001 
Glycemic Load and LDL Cholesterol  
Glycemic Load  0.03 -0.03 to 0.09 0.28 
Gender -13.34 -23.63 to -3.04 0.01 
Lipid lowering drugs -28.15 -33.80 to -22.50 <0.001 
BMI -0.74 -1.29 to -0.19 0.01 
Constant  n=547 161.17 135.72 to 186.63 <0.001 
Glycemic Load and Total Cholesterol:HDL Ratio 
Glycemic Load  0.00 -0.001 to 0.003 0.262 
Lipid lowering drugs -0.77 -0.968 to -0.579 <0.001 
Constant  n=568 4.48 4.184 to 4.785 <0.001 
Glycemic Load and HDL:LDL Ratio  
Glycemic Load  0.000 -0.000 to 0.001 0.541 
Lipid lowering drugs 0.125 0.087 to 0.162 <0.001 
Time  0.015 0.000 to 0.030 0.045 
Constant n= 549  0.374 0.315 to 0.434 <0.001 
Glycemic Load and Log Triglycerides 
Glycemic Load  0.00 -0.00 to 0.00 0.08 
Lipid lowering drugs -0.13 -0.22 to -0.04 0.004 
Age -0.01 -0.01 to -0.00 0.01 
Physical activity -0.01 -0.01 to -0.00 0.01 
Constant  n=562 5.41 5.03 to 5.79 <0.001 
52 
 
Figure 1 Participant Flow Diagram 
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CHAPTER IV 
 
The Association between Glycemic Index, Glycemic Load and Anthropometrics 
among Low-income Latinos with Type 2 Diabetes 
 
 
ABSTRACT 
 
Background 
Obesity is an independent risk factor for the development of cardiovascular disease 
frequently associated with hypertension, dyslipidemia, and insulin resistance, and is 
prevalent among individuals with type 2 diabetes and in Latino populations. 
Improvements in anthropometrics, such as BMI and waist circumference, have been 
shown to result in improved insulin sensitivity. Few clinical trials have investigated the 
association between lowering glycemic index or glycemic load and anthropometrics in 
patients with type 2 diabetes and none with Latinos.  
Purpose 
The purpose of this study was to determine the effect of reducing glycemic index or 
glycemic load on anthropometrics determined via BMI, body weight and waist 
circumference among low-income Latino individuals with type 2 diabetes. 
Methods 
Latino patients with type 2 diabetes participated in a 12 month randomized clinical trial 
testing the efficacy of a diabetes self-management intervention. The group-based 
intervention targeted diabetes knowledge, attitudes and behavioral capabilities and its 
content was tailored to the cultural and literacy needs of the population. Measurements 
were collected at baseline, 4 and 12-month follow-up and included three 24-hour dietary 
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recalls, clinical assessments, and demographic and psychosocial interviews at each 
time point. Multivariate random effects analyses were used to test the association 
between GI and GL with anthropometrics overtime. 
Results 
A total of 252 Latino adults with type 2 diabetes participated in the study. The baseline 
mean ± SD HbA1C was 8.98% ± 1.87, age was 55.98 ± 11.18 years, and 76.59% were 
female. A reduction in glycemic index was positively associated with the reduction in 
waist circumference (p=0.003), but not with BMI (p=0.244) or body weight (p=0.456). No 
significant associations between glycemic load and BMI, body weight or waist 
circumference were found (p=0.474, p=0.079 and p=0.127, respectively) overtime. 
Conclusion 
While the results of this study suggest a benefit of lowering glycemic index on one 
anthropometric marker, no beneficial effect of lowering glycemic index was associated 
with other anthropometric markers and results showed no beneficial effect of lowering 
glycemic load on any of the anthropometric measures.  
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INTRODUCTION 
Latinos suffer higher rates of overweight and obesity compared to non-Latino 
whites. According to data from 2003-2004 the prevalence of overweight and obesity 
among adults over the age of 20 years, was 64.2%  for Non-Latino Whites compared to 
73.4% for Mexican Americans [63]. The International Day for Evaluation of Abdominal 
Adiposity (IDEA) Study of a primary care population within Latin America and the 
Caribbean region reported that nearly 70% of the primary care patients were overweight 
or obese. Abdominal obesity, defined as waist circumference ≥90 for men and ≥80 cm 
for women, was present in 70% of men and 76% of women [64]. 
The increases in overweight, obesity and abdominal adiposity are associated 
with T2D [64]. Results of The IDEA study suggest that the prevalence of T2D increased 
across BMI and waist circumference groups. Age adjusted odds ratios for T2D by BMI 
were 1.20 for overweight men and 1.61 for overweight women and 1.90 for obese men 
and 2.77 for obese women compared to normal weight individuals. Age adjusted odds 
ratios for T2D by waist circumference were WC ≥90/80 vs <90/80 cm 1.63 for men and 
2.86 for women and WC >102/88 vs ≤102/88 cm1.68 for men and 2.53 for women [64]. 
Despite the elevated prevalence and the extreme health and financial burden 
associated with overweight, obesity and T2D, successful prevention and treatment of 
these conditions remains a challenge. 
Previous research suggests that improvements in dietary behaviors can have 
beneficial effects on diabetes management. The American Diabetes Association’s 
(ADA) evidence-based treatment guidelines include specific dietary recommendations in 
conjunction with pharmacological interventions and other self-management strategies  
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(i.e., blood glucose monitoring and physical activity) [16]. Recommendations for dietary 
management for individuals with T2D emphasize the implementation of lifestyle 
changes that will improve body weight, glycemia, and dyslipidemia. Modest weight loss 
(≥5% of body weight) in overweight individuals with T2D has been shown to improve 
insulin resistance, measures of glycemia, and lipid profiles [65]. The ADA recommends 
dietary intake of carbohydrates from various sources including: fruits, vegetables, whole 
grains, legumes, and low-fat milk. The ADA’s current position [16] suggests the use of 
the glycemic index (GI) and glycemic load (GL) as a strategy for improving diabetes 
management. Both may offer some benefit over that seen when total carbohydrate is 
considered alone.  
Blood glucose response to the ingestion of carbohydrate-containing foods has 
been shown to vary dramatically depending on factors including the molecular structure 
of the carbohydrate, fiber content, and degree of processing [17]. Refined, highly 
processed carbohydrates are broken down and absorbed quickly, resulting in a rapid 
increase in blood glucose, whereas less refined carbohydrates are absorbed more 
slowly, resulting in a slower, more sustained rise in blood glucose. GI is the value given 
to carbohydrate-containing foods indicating the blood glucose response they elicit. The 
GI [5] of a food is defined as the incremental area under the glucose response curve 
relative to that produced by a standard control food (either glucose or white bread). To 
account for carbohydrate content variation with in foods, GL was introduced in 1997 by 
Willett and colleagues and can be calculated as the quantity (in grams) of a food’s 
carbohydrate content, multiplied by its GI [19]. Previous research has suggested that 
lowering GI might increase satiety, which in turn would decrease caloric intake and 
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result in weight loss. Other hypotheses have been suggested such as changes in 
postprandial blood glucose, as high GI foods produce exaggerated glycemic and 
insulinemic responses followed by a hypoglycemic state, potentially increasing hunger 
[17]. The purpose of this study was to determine the effect of GI and GL on 
anthropometrics determined via BMI, body weight and waist circumference among low-
income Latino individuals with T2D. 
 
METHODS 
Study Participants 
Patients with T2D were recruited from five community health centers (CHC) in 
urban areas of central and western Massachusetts.  At each CHC, a trained site 
research coordinator overseen by the research team was responsible for completing the 
recruitment processes. Subjects were included if they: were diagnosed with T2D;had an 
HbA1c level > 7.5; were currently  being treated with diet, oral hypoglycemics or insulin 
and, if they were currently on insulin, they must have had a history of prior therapy with 
diet alone or oral hypoglycemic agents; were Latino origin; were > 18 years old; had a 
telephone in home or easy access to one;  were able to understand and participate in 
the study protocol and functionally capable of meeting the physical activity goals; 
understood and could provide informed consent; and were given physician approval to 
participate in the study. Subjects were excluded if they: had a history of diabetic 
ketoacidosis; current gestational diabetes; were unable or unwilling to provide informed 
consent; had any plans to move out of the area within the 12-month study period; 
required intermittent glucocorticoid therapy within the past 3 months; experienced an 
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acute coronary event within the previous 6 months or had any medical condition that 
precluded adherence to study dietary recommendations or had any major psychiatric 
illness.   
Determination of subject eligibility and recruitment was conducted in several 
stages. First, health care providers at participating CHCs were notified of the study and 
their approval for the site research coordinator to access patient medical records for 
screening purposes was obtained. Second, a review of the medical records of 
potentially eligible patients’ was completed. For patients determined to be medically 
eligible to participate, approval and a signature on the recruitment letter was obtained 
from their primary care physician. Third, a letter describing the study was mailed to the 
patients who received primary care physician approval. Prior to participation in the study 
written informed consent was obtained from all participants. Once the baseline 
assessment was completed, participants were randomized to either the usual care 
condition or to Latinos En Control intervention condition. Randomization was completed 
at the level of the individual and stratified by CHC site, gender, baseline HbA1c levels 
and insurance status. Within each strata, participants were randomized in randomly 
allocated blocks of size 2, 4 and 6 using a reallocation program [30] version 7.0 (Stata 
Corporation, College Station, TX). Block randomization was used to ensure blinding of 
the allocation sequence. The study protocol was approved by the University of 
Massachusetts Medical School’s and the Baystate Medical Center’s Institutional Review 
Boards. 
Intervention 
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Participants in the intervention condition, Latinos en Control, participated in a one 
year, group based intervention, consisting of two phases: an intensive phase with 12 
weekly sessions followed by a maintenance phase with 8 monthly sessions. An outline 
of the self-management curriculum is presented in Table 1. The intervention targeted 
diabetes knowledge (e.g., effect of foods of different GI on diabetes control), attitudes 
(e.g., self-efficacy for dietary change) and behavioral capabilities (i.e., skills needed to 
make lifestyle changes) with its content tailored to the cultural and literacy needs of this 
population.  Personalized coaching was offered during 10-minute counseling segments 
prior to the start of each group.  
The dietary component of the intervention used the metaphor of a traffic light to 
simplify complex concepts. Foods frequently consumed by Latinos were classified 
based on their GI, fat, salt, and fiber content into categories of “green”, “yellow,” or “red” 
foods. A “food guide” which included pictures of these foods within the corresponding 
“traffic light colors” was developed and provided to all participants. Additionally, 
participants were given a graphic of a plate which displayed the ideal balance of colors 
at any given meal. Explained simplistically, the color green classified recommended 
foods which were lower in calories, saturated or trans-fat and sodium content and were 
of lower GI.  “Yellow” foods were medium in calories, saturated or trans-fat and sodium 
content and were of medium GI.  “Red” foods were higher in calories, saturated or 
trans-fat and sodium content and were of higher GI. To impact GL, reduction of portion 
sizes was emphasized and all participants received a set of measuring cups. Subjects 
participated in multiple interactive sessions including: healthy cooking methods for 
ethnic foods, label reading, a supermarket tour, group meals where measuring cups 
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were used for modeling appropriate portion sizes and guided discussions explored taste 
and appeal of the foods, the ease of preparation, and strategies to incorporate new 
cooking methods at home. Participants were provided with and instructed in the use of 
glucose meters and step counters.  
Usual care was defined as diabetes care as currently delivered at the CHC. 
Therefore, participants in the usual care group received medical therapy as determined 
to be appropriate by their healthcare providers. Healthcare providers received all 
laboratory reports for all participants regardless of their study condition. 
Measurement 
Measurements were collected at baseline, 4 and 12-month follow-up and 
included three 24-hour recalls, clinical assessments, and demographic and 
psychosocial interviews at each time point. Dietary intake and physical activity [31] were 
assessed via three unannounced telephone administered 24-hour recalls. Multiple 
recalls are used to assess day-to-day intra-individual variations in the behaviors of 
interest [32]. The Minnesota Nutrition Coordinating Center’s (UM-NCC) Nutrition Data 
System for Research software (NDS-R) was used to collect and analyze the 24-hour 
dietary recall data [33].  At each assessment visit, fasting blood samples were drawn for 
analysis of TC, LDL, HDL and triglycerides, fasting glucose, and HbA1c.  Body Mass 
Index (BMI) was calculated as weight in kg divided by height in cm². Weight was 
assessed with a Tanita BWB800S Digital Physicians Scale and Height was asses with a 
Seca Road Rod Portable Stadiometer.  Waist circumference was measured in 
centimeters to 0.1 cm.  Waist circumference was measured twice and the mean value 
was used in the analyses. Two blood pressure measurements were taken using a 
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Dinamap XL automated BP monitor.  All medications and supplements were recorded. 
Demographic and additional data were collected via self-reported survey, including; 
age, gender, education level, and duration of diabetes. In order to account for the 
potential effect of medications on blood glucose, lipids, and weight, two pharmacists 
compiled the medication used by study participants based on whether they had a 
positive or adverse effect on these outcomes. In addition, glucose lowering agents were 
combined to construct a diabetes medication intensity score. This score was based on 
the type of oral hypoglycemics taken and/or dose and type of insulin taken. Possible 
scores ranged from 0- 6.5, with a higher score equating to greater number or dose of 
medication/insulin. Participants were compensated with 30 dollars at each assessment 
timepoint. 
 
Statistical Analysis 
All analyses were performed using STATA version 11. (StataCorp, College 
Station, TX) Results are expressed as means with 95% confidence intervals (CIs). 
Descriptive statistics were calculated for continuous covariates (age, physical activity, 
blood pressure, medication score), exposure variables (GI, GL), and outcomes (BMI 
body weight and waist circumference). Although GI and GL were continuous variables, 
for univariate statistical inferences, we stratified baseline demographic and clinical data 
by baseline GI and GL quartile and compared differences by Chi-Square or ANOVA 
tests.   
          Four separate random effects regression models were developed with either the 
outcome being BMI or waist circumference, and the primary predictor of interest being 
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the exposure variable of GI or GL (ie, a model examining the effect of GI on BMI 
adjusted for other confounders, followed by a model examining GL on BMI and then 
repeated for waist circumference).  Each model was controlled for age, gender, mean 
arterial blood pressure, total energy intake, physical activity, diabetes medication 
intensity score, lipid increasing and decreasing drugs, and weight increasing and 
decreasing drugs and study arm. A backward elimination process was used for each 
model, until only significant variables remained. Additionally, linear regression was used 
to determine the association between change in glycemic index and glycemic load with 
change in BMI, body weight and waist circumference from baseline to 4 months follow-
up.  
The primary multivariate analysis was a complete case analysis in which patient 
records with missing values were not in the regression models.  To investigate the 
potential effect of missing data, two imputed sensitivity analyses were completed. The 
first analysis was intention to treat analysis, which included all 252 randomized 
participants, with the baseline observation carried forward when missing values were 
present. The second method relied on multiple imputation by chained equations (MICE) 
analysis [34]. No differences were found between the analyses. Thus, results using 
complete data are presented herein. 
RESULTS 
Baseline Characteristics 
The participant flow diagram is shown in Figure 1. A total of 252 Latino adults 
with T2D participated in the study. Although all anthropometric outcomes were 
continuous variables in these analyses, for purposes of baseline inference, we stratified 
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baseline demographic and clinical data by baseline quartile of BMI and waist 
circumference (see Table 2b). The baseline mean (SD) BMI was 34.76 kg/cm² (±6.94), 
waist circumference was 111.69cm (±13.99), body weight was 192.17 lb (±39.94), age 
was 56 years (±11.18), and 76 % were female. Baseline mean total energy intake was 
1700.73 Kcal., mean GI was 61, and mean GL was 127.  At baseline there was a 
significant difference in BMI quartile by gender. Notable was that subjects in the highest 
quartile of BMI and waist circumference had significantly higher diabetes medication 
intensity scores compared to those in the other three quartiles (p=0.05 and p=0.02, 
respectively). At baseline 44% of subjects were taking oral hypoglycemic medications 
only, 40% were taking oral medication and insulin, 9% were taking insulin therapy only 
and 7% were taking no medications. Subjects in the highest waist circumference 
quartile had significantly higher GL compared to the other three quartiles (p=0.05).  
Change in GI and GL  
A significant reduction (baseline minus 4 month value) in mean GI was seen in the 
treatment group at 4 months (treatment -2.57 (7.25) vs. control 0.87 (5.95), p<0.001).  
However, while this trend remained, the difference between conditions was no longer 
statistically significant at 12 months (treatment -0.63 (7.15) vs. control 0.42 (5.96) vs., 
p=0.27). A significant reduction in mean GL was seen in the treatment group compared 
to the control group at 4 months (treatment -20.42 (46.87) vs. control 7.41 (44.12), p 
<0.001), and at 12 months (treatment-14.62 (46.82) vs. control 6.48(43.15), p <0.001).   
There was a significant association between change in glycemic index and change in 
waist circumference from baseline to 4 months follow up. There was no statistically 
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significant association between change in glycemic index or glycemic load with change 
in BMI or body weight from baseline to 4 months follow up.  
Overall Association of Glycemic Index and Anthropometrics 
Table 3b illustrates the results of the multivariate longitudinal random effects model 
analyses. A reduction in GI was positively associated with the reduction in waist 
circumference (0.154, 95%CI [0.053 to 0.256, p=0.003), but not with BMI (-0.024, 
95%CI [-0.064 to 0.016], p=0.244) or body weight (0.062, 95%CI [-0.101 to 0.225], 
p=0.456) overtime. 
Overall Association of Glycemic Load and Anthropometrics 
No significant associations between GL and BMI, body weight or waist circumference 
were found (-0.002, 95%CI [-0.008 to 0.004], p=0.474, and 0.021, 95%CI [-0.002 to 
0.045] p=0.079) and 0.012, 95%CI [-0.003 to 0.028], p= 0.127, respectively) overtime. 
DISCUSSION  
The result of this study showed that a reduction in GI was positively associated 
with improvement in waist circumference but not with BMI or body weight. No significant 
associations between GL and any anthropometric outcomes were noted. Similar to our 
findings, several previous clinical trials conducted among adults with T2D have reported 
beneficial effects of lowering GI on some anthropometric outcomes, but not others. 
Three studies have investigated the impact of a low GI diet compared to a high GI diet 
on anthropometric outcomes in individuals with T2D. Results of one study suggest that 
body weight did not differ significantly between diets [10]; another found no difference in 
lean or fat mass between the two diets [9]. Only one study has previously investigated 
the effect of lowering GI in Latino subjects with T2D. Jimenez-Cruz et al. [28] conducted 
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a 6-week crossover feeding study in which 14 overweight and obese Mexicans 
Americans with T2D were given a low-GI diet, containing Mexican-style foods and then 
a high GI diet. The results showed that BMI and body weight significantly decreased 
during the low GI diet compared to the high GI diet.  Unlike the Latinos En Control 
study, the previous research on this topic was conducted with small sample sizes and 
the dietary conditions were of short duration, most lasting less than 6 weeks.  
Previous research suggests that increased BMI is associated with hypertension, 
dyslipidemia, T2D, and insulin resistance [66, 67].  However, BMI does not assess body 
fat distribution which might be a stronger predictor of metabolic risk. Abdominal fat can 
be accessed through various measures such as waist circumference or waist-to-hip 
ratio. Data suggests that increased waist circumference is associated with increased 
risk for metabolic diseases including metabolic syndrome and CVD, independent of BMI 
[68, 69]. Furthermore, observational studies suggest that elevated waist circumference 
levels, even among adults with a normal BMI, have a two to three fold increase in CVD 
risk and premature death [70-72].  
Recent research suggests that within the Latino population, waist circumference 
is associated with increased rates of cancer, stroke, myocardial infarction and all-cause 
mortality [68, 73, 74]. One study reported that increased waist circumference is 
positively associated with clustering of multiple metabolic syndrome factors (including 
fasting blood glucose, triglycerides, blood pressure, waist circumference and HDL 
levels) in Latino men and increased fasting insulin concentrations in Latino women [75]. 
Recently, a National Institute of Health expert panel and the NCEP ATP III 
criteria suggested that waist circumference measures of >102 cm for men and >88 cm 
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for women be used to identify individuals with increased risk for obesity related co-
morbidities [76, 77]. The mean waist circumference for individuals in this study was 
111.85 cm for females and 111.11cm for males. In comparison, results of the IDEA 
study showed that the mean waist circumference in a Latin American primary care 
population, which was predominantly overweight and obese, was 96.4 and 89.7 cm for 
men and women [64]. Thus subjects in the Latinos en Control trial had very high mean 
waist circumference. The result of this study showed that a reduction in GI was 
positively associated with improvement in waist circumference. A 1 unit decrease in GI 
(in its original units of measurement) resulted in a 0.15 cm. decrease in waist 
circumference.  
The result of this study showed no association between GI and BMI or body 
weight and no association between GL and any anthropometric outcomes. One possible 
explanation for the lack of effect of GI and GL on BMI and body weight and the minimal 
effect of waist circumference is that the decrease in GI and GL may not have been 
clinically significant. The mean GI of this population was 61 (glucose reference), which 
is lower than expected. Additionally the absolute reduction in both GI and GL was very 
small in the present study. Greater reductions in GI and GL might be needed to see a 
more significant reduction in anthropometric outcomes. However, as this population had 
a lower mean baseline GI greater reductions may be difficult.  
Another possible explanation for the lack of significant findings may be that while 
the physiological mechanisms by which GI and GL impact blood glucose are well 
established, the mechanisms by which GI and GL impact anthropometrics are less 
understood. Previous research has suggested that lowering GI might increase satiety, 
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which in turn would decrease caloric intake and result in weight loss. A recent analysis 
of 32 studies showed that low GI foods have a higher satiating effect than high GI foods 
[78]. However, due to a large number of confounding variables within the included 
studies, the authors were unable to conclude that low GI diets mediate changes in body 
weight. Thus, the mechanism by which GI affects satiety is unclear.  Possible 
hypotheses have been posited such as changes in postprandial blood glucose or 
regulator hormones. Compared to low GI foods, high GI foods produce exaggerated 
glycemic and insulinemic responses followed by a hypoglycemic state, potentially 
increasing hunger [17].  
The results of this study are subject to several limitations. First, dietary data were 
collected via self report. Second, 24-hour dietary recall was conducted in Spanish and 
translated by the assessor into English. Third, previous research suggests 
underreporting of dietary intake in Latino populations [38]. Fourth, all participants were 
from Massachusetts, and thus represent a limited geographic range; all subjects were 
Latino, thus results may not be applicable to all racial and ethnic groups or those in 
other states. Finally, the majority of subjects were Puerto Rican. Previous research has 
suggested that variations exist between subgroups of Latinos thus generalizations 
regarding Latinos as a single ethnic group should be made with caution.  
This study addressed a significant health concern within a population at great risk. 
Overweight and obesity are independent risk factors for the development of CVD. 
Latinos suffer higher rates of overweight and obesity and subsequent T2D compared to 
non-Latino whites. While the results of this study suggest a benefit of lowering glycemic 
index on one anthropometric marker, no beneficial effect of lowering glycemic index was 
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associated with other anthropometric markers and results showed no beneficial effect of 
lowering glycemic load on any of the anthropometric measures. Two important issues 
which should be strongly considered in future research are the baseline GI and GL of 
the target population, and the ability to achieve clinically significant reductions in GI and 
GL.  
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Table 1b 
Latinos En Control Diabetes Self-Management (DSM) Curriculum: Session Objectives and Topics 
 
Session 
number 
Intensive Phase 
1 Rapport with patients; individual assessments of:  diabetes self management (DSM) history; DSM goals and 
incentives; expectations and commitment for the program; family support and resources for DSM; rationale 
for DSM; begin  
2 Group cohesiveness (i.e., icebreaking exercises); what is diabetes; meeting and working with a new health 
care provider; physical activity self-monitoring (step counters); begin walking and physical activity self-
monitoring.  
3 Attitudes toward healthy eating; healthiest foods (“Green” section of the Traffic Light Food Guide); 
communicating with dietitians; begin self-monitoring of food intake.  
4 Review of “Green” foods; portion control (“Yellow” section of the Traffic Light Food Guide); common 
challenges to self-monitoring of food intake.  
5 Review dietary concepts introduced up to now; behavior changes made up to now; foods to avoid or eat 
infrequently and in small amounts (“Red” section of the Traffic Light Food Guide); management of 
hypoglycemia and self-management; communicating with health care providers  
6 Mid-program review: physical activity, dietary concepts, self-monitoring, understanding and practice of self-
management for glucose control, management of hypoglycemia. 
7 Medication adherence; cholesterol and blood pressure; diabetes complications; barriers and resources to 
self-management; what to ask from health care providers. 
8 Foot care; infections; smoking; stress management; getting support from the health care system. 
9 Food labels and label reading skills; saturated fat, sodium and fiber. 
10 Food Shopping, Quick meals.  
11 Review food shopping strategies; heart healthy eating; management of sick days; following provider 
recommendations. 
12 Program review; future challenges to maintenance; keeping in touch with health care providers. 
 Maintenance Phase 
13 Review of self-management concepts; continuing to increase physical activity 
14 Progress toward healthy eating; new ideas for increasing healthiest foods; continuing to self-monitor self-
management behaviors; problem-solving challenges as a group.  
15 Managing challenges to portion control and avoiding unhealthy foods; Moving more. 
16 Review of self-management experiences. 
17 Medication adherence; cardiovascular risk factors and diabetes complications. 
18 Staying healthy and reducing stress. 
19 Future challenges to maintenance of behavior change. 
20 Review and graduation  
70 
 
Table 2b 
Baseline Characteristics (mean and percentages) by Quartile of BMI and Waist Circumference 
 Quartile BMI Quartile WC 
 1(lowest) 2 3 4(highest) p 1(lowest) 2 3 4(highest) p 
range 19.2-29.9 30.0-33.5 33.5-38.9 
 38 95683 
39.0-55.7  78.7-114.5 95.0-123.6 99.0-148.7 107-163.5  
n 62 62 62 63  62 63 63 63  
Intervention 
G  
51.61       46.03       44.44       53.97 0.67 53.23 46.03 50.79 46.03 0.80 
Glycemic Load 121.86 116.25 138.10 129.39 0.06 118.30 124.28 122.45 141.15 0.05 
Glycemic Index 61.18 60.51 61.17 60.94 0.88 60.32 61.65 60.64 61.14 0.50 
Age 57.97 57.76 54.95 53.47 0.06 56.71 57.90 55.77 53.75 0.20 
Gender (Female) 64.52       74.60       77.78       88.89 0.02 75.81       73.02 79.37       77.78 0.85 
Medication 
S  
2.572 3.10 2.67 3.31 0.05 2.44    2.71    3.22    3.27   0.02 
Physical 
A ti it  
13.85 12.30 11.16 13.29 0.12 14.77 11.02 13.05 11.82 0.01 
Marital Status 
(Not married) 
59.02 62.30 
 
53.23 68.85 0.35 61.67 58.06 66.13 57.38 0.74 
Income           
<10,000 48.00       65.52       57.41       48.15  50.00 56.14 60.38 53.70  
10,000-20,000 42.00       29.31       33.33       44.44  38.46 36.84 33.96 33.96  
>20,000 10.00        5.17        9.26        7.41 0.50 11.54 7.02 5.66 7.41 0.92 
Education           
<= high school 74.19       82.54       76.19       69.84 0.41 74.19 84.13 73.02 71.43 0.34 
HbA1c  (%) 9.02 9.1 8.62698 9.17 0.34 9.01 8.94 8.91 9.10 0.94 
FBG (mmol/L) 176.25 158.71 163.66 176.63 0.39 168.92 163.17 167.29 175.78 0.80 
BMI (kg/m) na na na na  28.46 31.764 35.65 43.08 0.00 
WC 97.68 107.40 113.33 128.15 0.00 na na na na  
Mean Arterial 
P  
98.84 96.05 96.41 94.70 0.23 95.42 98.26 97.02 95.25 0.40 
Total cholesterol 180.16 188.60 181.32 177.08 0.55 183.45 184.90 181.92 176.94 0.79 
HDL cholesterol 44.87 45.87 42.90 43.65 0.29 46.61 43.60 44.06 43.05 0.15 
LDL cholesterol 106.44 109.98 105.85 105.13 0.90 105.88 110.30 107.38 103.75 0.81 
VLDL 
h l l 
26.19 30.38 30.13 26.61 0.19 27.95 30.53 26.41 28.46 0.43 
Triglyceride 160.95 161.89 155.83 146.27 0.85 155.69 161.27 152.68 155.21 0.98 
Total Energy 1669.69 1605.75 1797.89 1719.96 0.30 1646.87 1624.27 1691.88 1837.87 0.17 
Total 
C b h d  
215.48 206.38 240.85 227.12 0.09 211.74 215.72 217.34 246.14 0.07 
Total Fiber 16.15 14.10 14.87 15.13 0.36 16.05 14.34 14.65 15.28 0.47 
Soluble Fiber 4.822 4.354 4.367 4.61 0.58 4.87 4.29 4.26 4.76 0.28 
Insoluble Fiber 11.22 9.60 10.29 10.38 0.27 11.09 9.80 
 
 
10.27 10.39 0.47 
Total Fat 56.82 55.24 60.49 60.89 0.54 57.28 53.88 58.40 64.26 0.15 
Saturated fat 17.79 18.02 18.77 19.53 0.68 18.12 17.39 18.14 20.58 0.19 
Trans fatty Acids 2.68 2.89 2.81 3.15 0.61 2.90 2.63 2.79 3.23 0.37 
71 
 
Table 3b  
Multivariate Random Effects Analyses of the Relationship between Glycemic Index and 
Glycemic Load with Anthropometrics 
Glycemic Index and Anthropometrics  
Glycemic Index and BMI  
Covariate Coef. 95% CI P>|z| 
Glycemic Index  -0.024 -0.064 to 0.016 0.244 
Age -0.129 -0.205 to -0.053 0.001 
Gender -3.025 -5.041 to -1.008 0.003 
Constant 47.207 41.640 to 52.774 <0.001 
Glycemic Index and Body Weight 
Glycemic Index  0.062 -0.101 to 0.225 0.456 
Age -1.291 -1.714 to -0.867 <0.001 
Gender 11.366 0.116 to 22.616 0.048 
Constant 246.249 216.723 to 275.774 <0.001 
Glycemic Index and Waist Circumference  
Covariate Coef. 95% CI P>|z| 
Glycemic Index  0.154 0.053 to 0.256 0.003* 
Lipid increasing drugs 1.160 0.263 to 2.056 0.011 
Constant 101.586 95.161 to 108.010 <0.001 
Glycemic Load and Anthropometrics 
Glycemic Load and BMI  
Covariate Coef. 95%  CI P>|z| 
Glycemic Load  -0.002 -0.008 to 0.004 0.474 
Age -0.129 -0.205 to -0.053 0.001 
Gender -2.996 -5.018 to -0.974 0.004 
Constant 46.013 40.976 to 51.050 <0.001 
Glycemic Load and Body Weight 
Glycemic Load  0.021 -0.002 to 0.045 0.079 
Age -1.276 -1.701 to -0.851 <0.001 
Constant 260.515 236.062 to 284.967 <0.001 
Glycemic Load and Waist Circumference  
Covariate Coef. 95%  CI P>|z| 
Glycemic Load  0.012 -0.003 to 0.028 0.127 
Lipid increasing drugs 1.164 0.259 to 2.069 0.012 
Constant 109.459 106.756 to 112.162 <0.001 
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Figure 1 Participant Flow Diagram 
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CHAPTER V 
CONCLUSION 
This study aimed to answer several understudied yet important research 
questions that may help inform dietary recommendations for the treatment of T2D in 
Latino adults. The goals of this study were to investigate the association of GI and GL 
on measures of diabetes control, anthropometrics and lipid profiles among low-income 
Latino individuals with T2D. These research questions were addressed through 
secondary analysis of an RCT, Latinos en Control, which tested the efficacy of a 
diabetes self-management intervention that targeted GI and GL among two hundred 
fifty-two Latino patients of Caribbean origin with T2D. Data from the Latinos en Control 
study provided a unique opportunity to conduct a secondary data analysis to compare 
the effects of reducing GI and GL on metabolic and anthropometric outcomes among 
low income Latinos with T2D. 
Results showed that a reduction in glycemic index from baseline to 12 months 
was positively associated with a reduction in logHbA1c (p=0.006), HDL: LDL ratio 
(p=0.037) and waist circumference (p=0.003), but not with fasting glucose, triglycerides, 
TC, LDL and HDL, TC:HDL ratio or BMI. No significant associations were observed 
between glycemic load and any of the outcomes measured. 
The results of this study are similar to those found in previous research among patients 
with T2D. Several studies have shown that a lower GI diet is associated with greater 
improvements in glycemic control [6-10] while several have not [26, 27, 29], several 
studies have shown no improvements in anthropometrics [9, 10] while one study did 
[28],and  several studies have shown improvements in lipid profiles, including HDL, LDL 
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and TC [9, 26, 29] while one study showed no improvement in any lipid marker [6]. The 
results of the research to date suggest that the effects of lower GI and GL on 
anthropometric and metabolic outcomes among adults with T2D have been 
inconsistent. Further research is warranted.  
Implications for Future Research and Practice 
To our knowledge this is the first study to assess ab-libitum GI and GL in a Latino 
population using repeated 24 hour dietary recalls at multiple time points. A major finding 
this research was that the mean GI of this population was 61 (glucose reference), which 
is lower than expected, as most carbohydrate containing foods consumed in the United 
States are refined, higher-glycemic carbohydrates [18].The typical Western style diet 
contains many starchy foods such as potatoes, white breads and rice most of which  
have a GI greater than 70 (glucose reference).  It is possible that differences in the 
food-ways of the Latino population differ from that of the general US population; further 
research in this area is warranted. Another possible explanation for the findings of this 
study was that the absolute reduction in both GI and GL was very small in the present 
study. Greater reductions in GI and GL might be needed to see a more significant 
reduction in metabolic and anthropometric outcomes. Two important issues which 
should be strongly considered in future research are the baseline GI and GL of the 
target population, and the ability to achieve clinically significant reductions in GI and GL.  
Over the past 10 years, research into the concept of GI has increased significantly, 
building the body of available evidence. However, in reviewing the research conducted 
to date, it is apparent that several methodological issues will need to be addressed in 
future research. First, more precise dietary measurement tools, which systematically 
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assess individual dietary GI intake, need to be developed and validated. Second, future 
GI research should utilize validated methodologies and databases for determining the 
GI of  diets increasingly diverse populations.  
From a clinical practice perspective, opponents of the GI have suggested that the 
concept is too difficult to understand and incorporate into dietary change. While the 
scientific concept of GI is complex, teaching the principles of the concepts does not 
need to be. Clinicians should emphasize the replacement of high GI foods with low and 
medium GI foods. A similar approach can be taken in regards to GL. Another criticism is 
that some low GI foods are high in fat, which is a great concern for patients with T2D 
due to their increased risk of CVD. However, this is not the case when focusing on 
whole, unprocessed low GI foods, such as vegetables, fruits, intact or minimally 
processed whole grains, and legumes, all of which are associated with improved 
cardiovascular health. GI should not be the sole criteria by which to select a diet; but 
when considered along with nutrient density and other relevant factors may be a useful 
construct for improving dietary quality and decreasing morbidity and mortality.  
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